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Abstract 
Inflammatory bowel disease (IBD) is a chronic condition affecting the digestive system. 
It is characterized by periods of exacerbation and remission and often poses many 
difficulties for those living with the disease. Young adulthood is a period with many life 
transitions. These transitions coupled with living with inflammatory bowel disease 
present unique challenges for young adults. The purpose of this study was to explore the 
experiences of young adults living with inflammatory bowel disease. There was little 
qualitative research available on the topic ofliving with inflammatory bowel disease. It 
was decided that a phenomenological research approach would provide rich , in-depth 
description, and understanding of the experience. Three young adult women who met 
specific criteria participated in the research study. Collection of data occurred through 
un-structured interviews. Colaizzi's (I 978) method of data analysis, including bracketing 
of assumptions, was used to identifY seven essential themes, which when combined best 
describe the women's experience. The seven themes identified were: (1) dealing with 
symptoms: a constant struggle, (2) embarrassment trying to hide the condition, (3) 
uncertainty: it could flare up at anytime, (4) lost time: interfering with normal life, (5) the 
double edged sword: treatment can be as difficult as the disease, (6) needing to maintain a 
supportive environment and (7) accepting the challenge of living with IBD. Through 
phenomenological inquiry into the lived experience of these young adults with 
inflammatory bowel disease, a greater understanding of their experience was gained. This 
understanding helps to enhance nursing's knowledge base on the phenomenon. 
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Chapter 1 
Introduction 
Inflammatory bowel disease (ffiD) is a chronic condition that affects the 
digestive system, and includes both Crohn's disease (CD) and ulcerative colitis (UC). 
ffiD is characterized by periods of remission and exacerbation ; the latter often poses a 
number of challenges for those who live with the disease (Mussell, Boeker, Nagel, & 
Singer, 2004). Living with ffiD frequently requires long-term medication, 
hospitalization, and/or surgery as well as changes to lifestyle (Crohn 's and Colitis 
Foundation of Canada (CCFC), 2007). Many factors have an impact on how a 
particular individual may be affected by ffiD (Casati, Toner, deRooy, Drossman, & 
Maunder, 2000; Sainsbury & Heatley, 2005; Searle & Bennett, 2001 ). Age is one such 
factor, and although ffiD can occur at any age, many of those living with the disease 
are diagnosed between the ages of 15 and 25 years (CCFC), and as a consequence often 
experience many of the challenges of living with the disease during their young adult 
years, when they are facing a number of developmental issues (Ruchala & Clauson, 
2006). 
Despite the many difficulties associated with ffiD, qualitative research into the 
"lived" experiences offfiD is somewhat limited, particularly in the case of young 
adults, with quantitative research predominating (Vanderheyden, Verhoef, & Hilsden, 
2006). Yet developmentally, young adults are experiencing challenging life transitions 
and these transitions, coupled with living with a chronic condition such as ffiD, can 
create unique experiences, which need to be explored through rigorous inquiry. There 
is a growing literature on children 's and adolescents' experiences with ffiD (Nicholas 
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et al., 2007), but less research that focuses specifically on the young adult. Young 
adulthood usually covers the period from late teens to late or mid 30s, (Ruchala & 
Clauson, 2006). For this research I have identified it as from 19 to 29 years of age as 
that is the period when many individuals are establishing their adult roles. This is a 
study of young adults' experiences with IBD, using a qualitative, descriptive 
phenomenological approach that provides an in-depth description and understanding of 
the experience. This study was guided by the approach outlined by Colaizzi (1978) as 
this approach allows the researcher to "remain with the human experience as it is 
experienced" (p. 53). 
Background 
In order to gain an understanding of a person's lived experience with any 
chronic illness, a brief general overview of the scope of the problem and the etiology, as 
well as, disease manifestations is useful background in appreciating some of the 
challenges these individuals face. Since IBD is a chronic inflammatory disease of the 
bowel characterized by periods of exacerbation and remission, chronic recurrent 
destruction of tissues, as in the case oflBD, often leads to permanent scarring, which 
can impair gastro intestinal function (Thoreson & Cullen, 2007). 
IBD affects approximately 170,000 Canadians (CCFC, 2007). Most 
commonly, IBD first appears in persons between the ages of 15 and 25 years, but can 
first appear between the ages of 45 and 55 years (CCFC). It can also have an earlier 
onset; occurring in the pediatric population (Hugot & Bellaiche, 2007). According to 
epidemiological research being conducted at the University of Manitoba and funded 
by the CCFC, Canada is leading the world with the highest rate of CD and one of the 
highest ofUC. Many factors have been identified as being associated with the 
disease, and different explanatory theories have been developed, but the cause offfiD 
remains unknown. Causative factors of ffiD may include a genetic predisposition, as 
patterns of the disease tend to be of familial origin (Baumgart, 2008 ; Gomez, 2000; 
Lewis et al., 2007). While the exact cause is unknown, autoimmune dysfunction may 
also be implicated (Johnson, 2007). Although CD and UC are both classified under 
the term ffiD and both result in inflammation, each condition has unique features and 
so I will present a brief overview of each condition. 
Ulcerative colitis. Ulcerative colitis (UC) occurs only in the colon (the large 
intestine) and always affects the rectum, with disease continuing along the bowel from 
the rectum, and depending on the extent of disease can continue to the cecum 
(Thoreson & Cullen, 2007). UC is characterized by inflammation of the inner mucosa 
ofthe intestine, which results in ulceration that may cause abscesses and bleeding 
(Johnson, 2007). UC is also characterized by bloody diarrhea or sometimes 
constipation, depending on which part of the colon is affected (Thoreson & Cullen). 
False urges to defecate and tenemus (persistent pressure in the anus) can also be 
present, especially with rectal disease (Sabil, 2003). Abdominal pain, often felt in the 
left lower quadrant, is squeezing in nature and can radiate across the lower abdomen 
(Thoreson & Cullen). During an exacerbation an individual with UC may experience 
changes in appetite and weight, fever, chills, and sweats, along with the risk of 
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megacolon (non obstructive colon dilation and necrosis leading to potential 
perforation). 
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Crohn 's disease. Crohn 's disease (CD) is similar to UC but can occur anywhere 
from the mouth to the anus. It occurs most commonly in the terminal ileum extending 
to the cecum and ascending colon (Gomez, 2000). Like UC, CD is characterized by 
inflammation. Inflammation in CD can be patchy and frequently affects all layers of 
the intestinal mucosa, thus causing fistulas to develop (Johnson, 2007). CD is also 
characterized by abdominal pain, especially around the navel and in the lower right 
quadrant (Gomez). Pain is sometimes described as a steady, dull ache. It can be 
associated with a swollen abdominal mass and worsens with eating and during certain 
activity (Sabil, 2003). Discomfort can be accompanied by frequent diarrhea, fatigue, 
changes in weight and appetite, nutrient malabsorption, anemia, fistulas, abscesses, 
perianal disease, and even bowel obstructions. 
Extra-intestinal manifostations. Both CD and UC can have extra-intestinal 
manifestations (Baumgart & Sandborn, 2007). These include painful joints, 
osteoporosis (especially with steroid use), skin disease (erythema nodosum and 
pyoderma gangrenosum), fatty liver, primary sclerosing cholangitis, gallstones, kidney 
stones (especially with resection ofthe ileum), eye problems, blood clotting 
abnormalities, pancreatitis, and malnutrition. It is possible for some or all of these 
symptoms to occur during exacerbation or treatment. 
Understanding the pathophysiology ofiDD is important in providing insight 
into the potentially devastating effects living with mo can have for an individual . 
Given the wide range of symptoms that a person who has IBD may experience, living 
with IBD would affect many aspects of daily living. 
Rationale 
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Given the scope of the problem and the physical manifestations ofiBD, 
understanding the effect on individuals with this condition is important. As IBD is often 
diagnosed during adolescence and young aduJthood, and results in a wide range of 
physical and psychological challenges, describing and understanding the experiences of 
young adults who live with IBD is of utmost importance (CCFC, 2007; De Boer, 
Grootenhuis, Derkx, & Last, 2005 ; Mackner, Sisson, & Crandall, 2004; Nicholas et al. , 
2007). 
One important reason that an increased understanding of the experiences of 
young adults who live with IBD is needed, is the number of children who are now being 
diagnosed with IBD (Hugot & Bellaiche, 2007). Anywhere from seven to fifteen 
percent of those diagnosed with IBD in western countries are diagnosed in childhood. 
Given the chronic nature ofiBD, this means that these children will experience their 
young adulthood while living with IBD, thus reaffirming the importance of 
understanding what it is like to be a young adult living with IBD. 
A second reason that this research is important is that chronic diseases are 
increasingly given greater attention because of the costs and burdens of chronic 
diseases to individuals and society in terms ofhealth care costs, and lost time at work, 
as well as the decreased quality of life for the individuals who are affected (World 
Health Organization (WHO), 2005). Most of the discussion of chronic disease focuses 
on cancers, cardiovascular and respiratory diseases, and diabetes with not much 
reference to IDD (WHO). Yet IDD is an important health problem and we need to 
understand more of the impact of this chronic disease on individuals. IDD and irritable 
bowel syndrome are the most common causes of chronic intestinal diseases and use 
anywhere between 30 to SO% of gastrointestinal services in the world (McFarland, 
2008). 
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Living with a chronic disease such as ffiD requires adherence to long-term 
treatments (CCFC, 2007). These treatments are critical in order to obtain and maintain 
remission of disease symptoms. Despite the necessity of long-term treatment, there are 
a number of barriers that have been identified and that result in individuals not adhering 
to treatment (Turnbough & Wilson, 2006). These barriers include the experience of 
side effects, fear of side effects, and the person's inability to understand the need for the 
medication when the disease symptoms are in remission. Poor medication adherence is 
particularly problematic during disease remission (D'Inca et al ., 2008) and can lead to 
exacerbations of the disease. Exacerbations offfiD can have a huge impact on a young 
person's life, so prolonging and promoting periods of remission are essential . Gaining a 
better understanding of what it is like to be a young adult living with IDD may assist 
nurses and other health care professionals in their efforts to support and promote 
adherence to treatment and thus deal with some of the burden related to chronic disease. 
Finally, young adulthood is characterized by major periods oflife transitions, 
some of which may include attending post-secondary institutions and starting a career 
or getting a job, dating, and getting married, or developing a long term relationship, and 
beginning a family (Lenz, 2001 ; Ruchala & Clauson, 2006). It is also a period in life 
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when individuals find themselves more independent from their parents and take on 
greater responsibility. Independence, responsibilities, choices, changes, and stressors 
are elements of the transition experienced in young adulthood and present significant 
developmental challenges. These challenges, coupled with a chronic disease that 
revolves around the socially taboo and embarrassing subject of'bowels ' can impact 
significantly on all aspects of a young adult's life (Norton, 2004; Schneider & Fletcher, 
2008). 
My interest in the phenomenon of living with IBD also comes from my 
experience as a nurse. During my nursing career while meeting and working with 
individuals living with ffiD, the desire to understand this multidimensional 
phenomenon emerged. I subsequently explored the research literature on ffiD and 
found limited qualitative research on the experience of young adults living with this 
condition, despite the number of individuals who are affected. No research of this kind 
has yet been conducted in the province of Newfoundland and Labrador, Canada where I 
work and live. Most of the research that I found in the area ofiBD had been completed 
from a quantitative or medical perspective and included individuals with wide age 
ranges. While these studies have provided important information about the disease 
activity and measures of quality of life, they have provided little insight into what it is 
like to live with this condition on a daily basis (Daniel, 2001). Gaining an 
understanding of the experience ofiBD as " lived", is a necessary step in filling the 
knowledge gaps presently noted in the current research on ffiD. Based on this 
perceived knowledge gap, the potential impact ofiBD on the lives of young adults, and 
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my nursing observations, I decided that a deeper insight into young adults ' lived 
experiences offfiD wouJd be beneficia] to nursing and other heaJth professions. 
Research Question 
The specific research question was: What is the experience of living with 
inflammatory bowel disease for the young adult? 
Research Purpose and Objectives 
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The purpose of the research was to explore the experiences of young adults with 
IDD using a phenomenological approach developed by Colaizzi (1978) and specifically 
my objectives were to: 
1) describe their experiences; and 
2) gain a greater understanding of this experience. 
Chapter 2 
Literature Review 
A primary review of the literature on inflammatory bowel disease (IBD), 
Crohn 's disease (CD), and ulcerative colitis (UC) was conducted using CIN Alfl.,, 
EMBASE, and PUBMED data bases, to get an overview of the research completed on 
IBD, that I felt was most closely related to my proposed research . Since the focus of 
the research was on young adults living with ffiD, the search terms " inflammatory 
bowel disease", "Crohn' s disease", and "ulcerative colitis" were each paired with 
"lived experience", "young adults" and "qualitative research". Thirteen qualitative 
research studies were located on living with IBD and all of these are included in the 
review of the literature. An additional study (Finfgeld, 2000) was located in a 
textbook on chronic illness (Miller, 2000) and I included that as well. When I began 
my research only three of the qualitative studies had been published. 
A secondary review of the literature was conducted also using CINAI-ll., 
EMBASE, and PUBMED using the search terms " inflammatory bowel disease", 
"Crohn's disease", and "ulcerative colitis" combined with "chronic illness" and 
"concerns" or "psychological factors". These searches yielded a large number of 
quantitative articles, mainly related to quality of life, and those selected were based on 
the relevance of the findings to my study. For this particular section of the literature 
review I did not include those studies that were specific to young children, 
adolescents, or elderly. Much recent literature is on children and adolescents with 
IBD. I did include the article though if young adults were included in the study. In this 
9 
chapter I will first present a detailed review of those qualitative studies and a 
summary of relevant quantitative studies. 
Qualitative Research 
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Fourteen qualitative studies were located that addressed either living with 
inflammatory bowel disease (IBD), (Brydolf & Segesten, 1996; Daniel 200 l ; Dudley-
Brown, 1996; Hall, Rubin, Dougall, Hungin, & Neely, 2005; Nicholas et al ., 2007; 
Schneider & Fletcher, 2008), living with aspects ofiDD or treatment approaches 
(Fletcher & Schneider, 2006; Hall, Rubin, Hungin, & Dougall, 2007; Jamieson, 
Fletcher, Schneider, 2007; Rogers, Kennedy, Nelson, & Robinson, 2004: Rogers, 
Kennedy, Nelson, & Robinson, 2005), or living with a chronic disease that included 
IDD (Delmar et al., 2005 ; Delmar et al., 2006; Finfgeld, 2000). Some of the reports 
combined experiences with IDD and irritable bowel syndrome (IDS) as these two 
conditions share similar symptom experience and have some of the same dietary 
restrictions (Fletcher & Schneider; Jamieson et al .; Schneider & Fletcher), two were 
limited to individuals with UC (Brydolf & Segesten; Dudley-Brown), and the 
remaining studies included individuals who were diagnosed with IDD and included 
both CD and UC. Three ofthe phenomenological studies located were based on the 
same data set (Fletcher & Schneider; Jamieson et al.; Schneider & Fletcher), but had a 
slightly different focus. Two of the grounded theory studies were also based on 
common data, but each had a different focus (Hall et al ., 2005, 2007). Both studies on 
UC and medical appointment type preference came from the same data (Rogers et al ., 
2004, 2005), and the two studies on chronic disease that included UC, also came from 
the same data (Delmar et al. , 2005 , 2006). 
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The age groups of the participants in the studies varied somewhat. Five 
studies focused on young adults (Daniel, 2001 ; Finfgeld, 2000; Fletcher & Schneider, 
2006; Jamieson et al ., 2007; Schneider & Fletcher, 2008), one on children and 
adolescents (Nicholas et al., 2007), another on both adolescents and young adults 
(Brydolf & Segesten, 1996), while the remaining studies had a wider age range 
(Delmar et al., 2005; 2006; Dudley-Brown, 1996; Hall et al., 2005, 2007; Rogers et 
al ., 2004, 2005). The methodological approach by the researchers also varied. Seven 
were based on phenomenology (Daniel; Delmar et al ., 2005, 2006; Dudley-Brown; 
Fletcher & Schneider; Jamieson et al.; Schneider & Fletcher), four used grounded 
theory (Brydolf & Segesten; Finfgeld; Hall et al., 2005, 2007), one was based on an 
interpretive ethnographic approach (Nicholas et al.), and the remaining two studies 
were based on qualitative interviews with a subset of participants from a larger 
quantitative study on medical appointment preference for UC follow-up (Rogers et al ., 
2004, 2005). Despite these differences, they nevertheless provide important insight 
into what it is like to live with IBD. 
Living with IBD 
One of the earliest studies located on living with ffiD was by Dudley-Brown 
(1996), who conducted a pilot study using phenomenology. She included three 
participants aged 30-58 years (2 men and l woman) who had UC. This researcher 
wanted to find out what it was like for these participants to live with this condition. 
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Themes identified were related to the uncertainty of the course of the disease because 
of the remissions and exacerbations, how emotionally difficult fecal incontinence was, 
the importance of finding a successful treatment and having a normal life, how much 
the disease affected all aspects of their lives, and how they felt controlled by UC. Her 
participants did vary as to how helpful they found health professionals in dealing with 
their condition and some of the concerns that they had identified. The number of 
participants was too small to identify variation within some of the other themes. 
Also in 1996, a study by Brydolf and Segesten was published using grounded 
theory. It was a study of28 adolescents and young adults aged between 11 and 28 
years and based on the self-concept mode of the Roy Adaptation Model. The 
researchers wanted to explore how these individuals felt living with UC had affected 
their concept of self. Eleven of these individuals had an ileostomy; a condition that 
would have an effect on self-concept. The participants all identified how the disease 
created a "sense of alienation" both from themselves and their peers. The sense of 
alienation led to some restrictions in their lives that were influenced by how supported 
they felt, their level of self-confidence, and how mature they felt in dealing with the 
consequences of the disease. Support from parents and positive coping strategies made 
the disease process more manageable. 
Finfgeld (2000) used grounded theory to develop a theory of courage as a 
management strategy for chronic illness. She focused on young adults aged 20 to 39 
years and had some individuals with CD among the 21 participants (12 women and nine 
men); although the exact number with CD were not identified. All the participants had 
some type of long-term health problem. The core variable identified was termed 
"becoming and being courageous, and in this process individuals learned how to 
struggle with their health problems and concerns, understand how to handle these 
concerns, engage in behaviour that enabled them to move beyond their concerns and 
even help others, leading to the final outcome of being able to thrive and maintain 
personal integrity, i.e., become courageous. These phases were influenced by both 
intrapersonal (e.g ., hope and self-confidence) and interpersonal factors (e.g., role 
models, social sanctions, and health professionals). These findings suggest that 
courageousness in the face of a chronic illness is a learned behaviour. 
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Daniel (2001) used King's Theory ofGoaJ Attainment to study young adult's 
perspective of what it was like to live with ffiD . She used a "qualitative 
phenomenological descriptive method, (p. 85) as a means ofleaming about this 
perspective from five participants (2 women and 3 men) between the ages of 18-24 
years. Some of the concerns all participants had in common were those related to their 
body image. They attributed these body image concerns to the side effects of treatment 
and embarrassment from bowel incontinence, the need for support, and being 
understood. The second most frequent concerns were grouped under growth and 
development issues and highlighted the participants' desires of wanting to have a 
normal life and the concern over the effect the disease had on interpersonal 
relationships. Uncertainty about the disease and finding treatments that worked were 
also important; but not to all participants. 
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Hall and colleagues (2005) used grounded theory to understand the process by 
which individuals with a low quality of life come to understand and cope with IBD. 
They selected 31 participants (19 women and 12 men) who had scored the lowest on 
quality of life scores in a larger study on IBD. The participants varied greatly in age; 
being from 26 to 99 years of age. The core concept identified was "health-related 
normality" and this represented the social psychological process of the participants in 
their efforts to maintain normality despite the restrictions in terms of freedom, health, 
and normality that the disease imposed on them. The participants also identified a 
number of strategies that they employed in their efforts to maintain the normality they 
sought. These strategies were grouped under psychological, behavioural, social , and 
biomedical categories. Some of the strategies included learning to adapt and cope, 
making changes in lifestyle, planning trips around how available a toilet would be, 
seeking social support ofboth an informal and formal nature, and adhering to 
medication use. Embarrassment, the taboo associated with IBD, and lack of 
understanding surrounding the condition were definite barriers to the participant' s sense 
of normality. 
Delmar et al . (2005, 2006) published two studies from a larger study on living 
and coping with chronic illness. They used a phenomenological approach and 
interviewed 18 individuals; six had "type 1" diabetes, six were diagnosed with UC, 
and six had coronary occlusion. The participants were equally divided by gender in 
each of the three diagnostic categories and their ages ranged from 18 to 75 years. The 
first study focused on achieving self-harmony despite having a chronic illness. Self-
harmony was related to the ability to accept their health status and maintain hope for 
improvement in their life situation. Hope centered around expectations of treatment 
and being able to lead a "normal life" . The second publication focused on how 
participants viewed their chronic conditions and self-management of these conditions. 
Important to the participants ' experiences were living with the contradictory 
relationship between both independence and dependence when they had a chronic 
condition and the importance of choice in order to participate in self-management. 
The participants also recognized the role that guilt could play in self-responsibility 
and self-control when it comes to living with their chronic illness. The authors 
believed there were no differences in the findings related to the type of chronic illness 
the individuals experienced. 
As part of a larger quantitative study on quality of life in children and 
adolescents with ffiD, Nicholas et al . (2007) used an interpretive ethnographic 
approach to understand how these young individuals experienced this condition. 
They interviewed 80 children or adolescents between 7 and 19 years of age. Included 
in the group were 44 men and 36 women; 61 had CD and 19 UC. These participants ' 
experiences were grouped under three broad categories of challenges; I) concerns 
around symptoms and treatments, 2) a sense of vulnerability and lack of control over 
the disease process, and 3) negative self-concept and difference from peer group. 
Strategies that helped these young people cope with their condition were grouped 
under social support and personal resources such as having a positive outlook and 
identifYing other individual strengths. 
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Schneider and Fletcher, (2008) used the same data set as in the publication by 
Fletcher and Schneider (2006) and Jamieson et al. (2007), but with one less 
participant, to identify some of the negative impacts IDS or IDD had on the 
participants' lives. Seven women between 18 and 22 years of age participated in the 
study. Phenomenological analysis was used for this data. Schneider and Fletcher 
focused on the physical and emotional domains of these women's lives. The women 
identified symptom experience and limitations in both food consumption and physical 
activity as the main physical effects of the disease. They identified helplessness 
because of the lack of control over symptoms, embarrassment around "bowel" 
symptoms, and guilt over cancelled social events because of symptom experience as 
the main negative emotional outcomes of having IDS and/or IDD. The findings 
illustrate how pervasive these conditions can be on a person's life. 
Food as a Coping Strategy 
Food consumption has an impact on IDD and watching or omitting certain 
foods is one strategy used to manage this condition. Using phenomenology, Fletcher 
and Schneider, (2006) studied eight women between the ages of 18 and 22 years who 
had been diagnosed with either IDD or IDS, to understand the strategies that they used 
to cope with these conditions. Food and beverage consumption strategies, and in 
particular understanding the particular foods and beverages that acted as "triggers" for 
a flare-up, were identified as the most common strategies used. As a consequence 
these women learned to avoid these foodstuffs. The need to employ these strategies 
was especially important when the women were away from their homes for meals. As 
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a consequence they also learned healthier eating patterns and learned a great deal 
about the relationship between food and ffiD or IDS. The women acknowledged that 
stress was also a factor in their exacerbations and that the controlled use of food did 
not always prevent a flare-up. 
17 
A second publication exploring diet change necessitated by a diagnosis offfiD 
or IDS used the data from the same eight female participants as above (Jamieson et 
al. , 2007). Information from a 14-day food diary enhanced the data from the 
interviews conducted with the participants. The researchers identified three main 
themes that illustrated how diet was related to the women's condition; control of 
disease, support from family and friends, and adverse or negative behaviours. The 
focus in the article was on how the women determined their diet and the important 
factors impinging on this determination. They also examined what role the physician 
played in giving dietary advice, what they learned from experimenting with food, the 
quality and type of information they sought, and actual modifications they made to the 
food that they consumed. Modification of diet did play a big role in helping these 
women deal with their condition and symptom experience affected the modifications 
they made. Use of diet helped the women feel more in control of their lives. They 
also felt that many physicians did not do much beyond prescribe medication and knew 
little about the role of diet in these conditions. 
Experiences with Medical Treatment 
Individuals with ffiD are required to take long-term medication. Non-adherence 
to medication is a frequent problem among individuals with ffiD. Non-adherence to 
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medication was a prominent theme in the study by Hallet al . (2005). As a consequence 
the same researchers used grounded theory to further explore problems around 
medication use and identify some of the concerns around non-adherence (Hallet al ., 
2007). The same data set as used in the previous study (i.e., Hall et al., 2005) reported 
above was used. Use of medication was related to health behaviours, such as, accepting 
the illness and a need for medication, concerns about side effects and being on long-
term medication, and the impact of symptoms on their lives. Most of the participants 
engaged in self-management strategies and reported that the quality of relationships 
with their physicians varied a great deal . 
Two of the qualitative studies located on ffiD were part of a larger study that 
evaluated the change from a fixed appointment system to an open access follow-up 
with physicians (Rogers et al., 2004; 2005). The change in type of physician follow-
up was initiated in order to be more responsive to individuals with chronic illnesses. 
The qualitative part of the study used a phenomenological approach. The aim of the 
first publication was to describe the patients' experiences with the new arrangement, 
i.e., open-access follow-up. Twenty-eight individuals with IBD (CD = 11 and UC = 
17) and between the ages of22 and 68 years took part in unstructured interviews. 
There were 16 women and 12 men. Most of the participants liked the change in 
follow-up and felt it was more responsive to their needs for medical follow-up with a 
disease that has an uncertain course. Some of the reasons reported for liking the new 
system were they could get medical attention when they felt they needed consultation 
and they felt it gave them more autonomy in managing their disease. Participants, 
who were less likely to experience the change as positive, were those who felt less 
secure about the new arrangement or not wanting the responsibility for follow-up . 
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A second publication on the evaluation from a fixed-appointment to an open-
access follow-up focused on changes in patient behaviour following the initiation of the 
new appointment system (Rogers et al ., 2005). The same participants as the previously 
described study (Rogers et al., 2004) were included in this part of the study. In general 
the participants liked the new system as they felt it was more responsive to their needs 
and that it was more "patient-centered" and promoted a more equal relationship with 
the attending physician, than was present in the old system. Those participants that did 
not like the new system as well as the previous system of fixed-appointment approach, 
felt that their concerns were more marginalized than in the previous system where 
follow-up tended to be more inclusive. Recently diagnosed patients generally like the 
newer system better than patients who had been in long-term follow-up. Some of the 
problems seem to stem from how well the physician was prepared for the new system 
of follow-up and physician willingness to let patients be more involved in self-
management. 
Quantitative Research 
Besides the qualitative studies just described in some detail, a number of 
quantitative studies were located that help with understanding some of the factors 
associated with living with ffiD, and that would have an impact on an individuals " lived 
experience" with this condition. This section of the literature review includes some of 
these studies that seemed most pertinent. Many of the articles located in the search, 
--- -----------------
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covered research on ffiD pathophysiology, etiology, treatment and treatment outcomes, 
or surgery. Given the scope of my research I felt it was not relevant to include this 
research in the review of the literature. 
The majority of the quantitative studies or reviews addressed quality of life 
(QotL) and associated factors identified as important in living with mn. QotL is 
characterized as "an elusive concept approachable at varying levels of generality from 
the assessment of societal or community wellbeing to the specific evaluation of the 
situations of individuals or groups" (Felce & Perry, 1995, p. 51). With specific 
clinical populations it is an equally complex concept, because it is multidimensional 
and usually examines well being and functioning in the physical, psychological, and 
social areas of a person's life (Spilker, 1990). Many studies use generic Qofl measures 
such as the SF-36 and some the more specific Inflammatory Bowel Disease 
Questionnaire (ffiDQ) that is disease specific. 
While most of the quantitative research included in this section addressed QotL, 
the literature can be divided into three categories. These three categories are: 1) 
disease impact (Bemklev et al ., 2005; Casellas, Lopez-Vivancos, Badia, Vilaseca, & 
Malagelada, 2001 ; Kin ash, Fischer, Lukie, & Carr, 1993a; Zutshi, Hull , & Hanmel, 
2007); 2) coping (Kinash, Fischer, Lukie, & Carr, 1993b; Larsson, L06f, R6nnblom, 
& Nordin, 2008 ; Mussell et al ., 2004; Petrak et al ., 2001 ; Smolen & Topp, 1998;); and 
3) psychosocial functioning (Drossman, Patrick, Mitchell, Zagami, & Appelbaum, 
1989; Guthrie et al ., 2002; Turnbull & Vallis, 1995). 
c------------------------------------------------------ - -
Disease Impact 
The disease impact ofiDD is multidimensional and affects many areas of 
patient's lives. A study by Kinash et al . {l993a) described the impact ofiDD on daily 
life. Using a descriptive survey design, data that related to disease impact and patient 
characteristics were analyzed. In addition structured interviews were also used to 
elicit data. These respondents did not report that the disease had a high impact on 
their daily lives. They did have some concerns around their bowel symptoms. Two 
areas of their lives where there was some impact were social activities and sleep. 
Those participants who reported greater disease impact also reported lower levels of 
life satisfaction. Both age and gender were important in that individuals under 35 
years of age and women reported lower satisfaction with their lives. 
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The impact on quality of life may vary, depending on if the person is 
experiencing an exacerbation or a remission . In their 2001 research to determine the 
impact IDD has on various dimensions ofQofL, Casellas et al . used a survey design to 
elicit responses from 289 participants with IDD between the ages of25 and 42 years. 
During periods of exacerbation the QofL of these participants was decreased, with 
digestive and systemic symptoms having the highest impact, and social impairment as 
having the lowest impact. For those participants in remission, systemic symptoms and 
emotional functioning continued to be present and had the greatest impact on QofL. 
In another cross-sectional design study the QofL of 497 participants with IBD 
was assessed (Bemklev et al ., 2005). Participants had a mean age of 43.3 years and 
almost half were women. In this study participants who recounted medication related 
side effects from the prescribed steroids and/or immunosuppressive drugs they were 
prescribed reported a lower QofL. As well, having extra-intestinal manifestations, 
increased number of exacerbations, and being women were three factors associated 
with having a greater disease impact on QofL. 
22 
Zutshi et al . (2007) conducted a quantitative cross-sectional study using 
questionnaires to determine what factors affected CD and what made symptoms worse. 
They surveyed a patient population (N = 1220) with CD who ranged in age from 17 
years to greater than 70 years. A small percentage of the participants (1 0%) were 
between 17 and 25 years of age, but findings were not reported by age group. Resu lts 
suggested that disease symptoms negatively impacted employment and that factors such 
as food, lifestyle change, and alcohol were some of the factors that made symptoms 
worse. In general when participants experienced major changes in their lifestyle, such 
as job change or family changes, they reported that symptoms worsened. 
Some research has been conducted to examille how school and leisure 
activities or labour market participation is affected by ffiD (Calsbeek, Rijken, 
Bekkers, Dekker, & vanBerge, Henegouwen, 2006; Calsbeek, Rijken, Dekker, & van 
Berge Henegouwen, 2006). In the study on school and leisure activities, the 
researchers compared 5 groups with different diagnoses (IBD, chronic liver disease, 
congenital digestive disorders, celiac disease, food allergy) and a "normal" control 
group of758 individuals in total who ranged in age between 12 to 25 years (Calsbeek, 
Rijken, Bekkers, et al.). Respondents with IDD had a greater number of physical 
complaints and more fatigue than other clinical groups or normal participants, with 
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the exception of those with chronic liver disease, who were similar to IBD. For those 
with IBD other differences noted were the need for more frequent hospitalizations and 
greater use of prescribed drugs. School and leisure activities did not seem to be 
greatly affected, but these young people may have made the necessary adaptations. 
There was no reporting of differences, if any, between the younger (adolescents) and 
older participants (young adults). 
In the second study on the same population as in the previous study but 
excluding individuals 12 to 14 years of age, the researchers examined how 
characteristics associated with the disease, such as type of diagnosis, and burden of the 
disease, defined as physical complaints, anxiety and depression, disability, 
hospitalization, medications use, diet adherence, and toilet use, affected employment 
(Calsbeek, Rijken, & Dekker et al., 2006). The authors reported that individuals that 
had IBD had more limited opportunities to work than the normal comparison group. 
The finding was attributed to the frequent hospitalizations, use of daily medications, 
and frequent use of the toilet. This finding held when student and non-student groups 
were compared. The last two studies did not use QofL measures 
Coping 
Coping or how one manages various demands that taxes or threatens an 
individual has the ability to mediate the effects of a disease (Miller, 2000). Studies were 
located that examined the coping patterns of those living with IBD. The earliest study 
located was by Kinash et al. (1993b) and used the same participants and data as the 
study reviewed previously (i .e., Kinash et al., l 993a). The researchers examined the 
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coping patterns of 150 participants diagnosed with ffiD. The participants with ffiD 
reported that they used problem-oriented coping methods more often versus affective-
oriented methods. Problem-oriented coping is directed towards an action, e.g., 
modifying a diet, while affective-oriented coping is directed towards feeling, e.g., not 
being angry. The participants that used problem-oriented coping reported increased 
levels oflife satisfaction and the converse was true for participants using the affective-
oriented coping method. Coping methods may be a modifiable factor for those with 
IBD as these methods can be learned. 
Smolen and Topp (1998) used a descriptive design to study coping methods and 
how these methods affected perceived health, functioning, and well-being. Data from 
46 participants with ffiD was obtained. Participants were between the ages of 16 and 95 
years, mainly diagnosed with CD (n = 37), and were mainly female (n = 34). 
Participants who used more emotion-focused coping methods (i .e., responded 
emotionally to a situation) had lower scores on perception ofhealth, functioning, and 
well-being. In contrast to the previous findings by Kinash et al . (1993b), those 
participants who used problem-focused coping methods did not report an increased 
level of health, functioning, or well-being. Optimistic coping (i .e., positive thinking) 
though was predictive of better perceptions of health and well-being. 
In a survey design study of 1322 participants with ffiD, data were analyzed to 
determine disease specific and generic QotL and coping methods (Petrak et al., 200 l ). 
They compared QotL scores of patients with ffiD with QotL scores of people in the 
general population. Results indicated that when compared to the general population, 
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participants with ffiD have a decreased QofL. As well, depressive coping was strongly 
associated with decreased QofL. In contrast to other studies this research found that 
active coping during exacerbation was also associated with decreased QofL. QofL 
during an exacerbation may be lower than while in remission regardless of the type 
coping strategy used. 
A 2004 study to assess the concerns of patients with ffiD and the impact of 
psychological and disease factors on QofL, examined disease related concerns of72 
participants between the ages of 18 and 65 years who were living with ffiD; CD = 47 
and UC = 25 (Mussell et al .). They found that such things as medication side effects, 
having an ostomy, disease uncertainty, being a burden to others, energy level, and loss 
of bowel control were all high ranking disease concerns. Concerns did not vary greatly 
by disease category, but it did by gender with women having greater concerns. Types of 
coping strategies were also studied. The concerns identified were all significantly 
increased in participants that used depressive coping methods and these participants had 
lower scores on QofL measures. Depressive coping included such factors as self-pity, 
feeling helpless, being resigned to the situation, and withdrawing from social 
interactions and events. 
In the most recent study located, Larsson et al. (2008) examined QofL in 
participants with ffiD and how they coped with disease activity. Seven hundred and 
forty-two participants between the ages of 18 and 65 years with ffiD completed 
questionnaires. Participants with active disease reported lower QofL and higher 
emotional distress. This is congruent with the findings ofPetrak et al., 2001 . 
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Participants most frequently used optimistic (e.g., thinking positively), self-reliant (e.g., 
depends on self rather than others), and confrontive (e.g., facing the situation) coping 
strategies, but use of these strategies was not found to be a significant predictor of 
QotL. 
Psychosocial Functioning 
Psychosocial functioning is not always well defined but usually refers to a range 
of psychological conditions, but mainly depression and anxiety or self-esteem and body 
image, as well as how restricted a person is in terms of the social or leisure activities 
he/she is involved in or participation in school and/or work (Mackner, Crandall , & 
Szigethy, 2006). A number of the quantitative studies examined psychosocial 
functioning in participants with IDD. In an early study by Drossman et al . (1989), the 
researchers evaluated 150 participant questionnaires to measure QotL. The findings 
indicated that participants with IDD experienced a decreased psychosocial functioning 
and this was further decreased in participants with CD versus UC. The participants in 
the study reported concerns surrounding having surgery, degree of energy, and body 
image issues as factors that affected their psychosocial functioning. 
Not unlike Drossman et al . (1989), Turnbull and Vallis (1995) studied disease 
specific and psychological factors that influenced QofL. In their study 22 participants 
with a mean age of32 years completed questionnaires. The research findings indicated 
that disease activity did not predict QotL, but those participants with enhanced 
psychosocial functioning experienced greater QotL. The converse was true for those 
participants who reported more psychological distress. 
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In a cross-sectional study, results from the 116 participants who had a mean age 
of 45 .9 years and living with IBD (UC = 37, CD = 75, and unspecified = 4) were 
analyzed to determine the impact of disease and psychological status on health QofL 
(Guthrie et al ., 2002). Similar to previous research their findings indicate that both 
psychological symptoms (depression) and disease activity (severity of symptoms) 
contributed to decreased QofL. While no significant difference in severity of symptoms 
were reported by diagnostic category, participants with CD had higher scores for 
depression. When the researchers controlled for disease severity in their data analysis, 
they found no significant differences in the influence of depression on QofL. 
Casati and Toner (2000) reviewed the literature on psychosocial aspects ofiBD. 
They included 71 articles in their review. It was not a systematic review of the 
literature. Their intent was to present what was known about psychosocial aspects of 
IBD. Some of the main areas they identified were the extent to which disease symptoms 
such as decreased energy, poor body image or feeling dirty, isolation and being a 
burden on others, and a lack of information from physicians negatively affected 
individuals with IBD. Effective treatment ofiBD is suggested as one of the important 
factors in increasing life satisfaction and thus QofL (Janke, Klump, Gregor, Meisner, & 
Haeuser, 2005). 
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Summary 
In this chapter I have presented and reviewed research of both a qualitative and a 
quantitative nature. The qualitative studies I have reviewed covered research around 
living with IBD, food as a coping strategy, and experiences with medical treatment. The 
research on living with IBD presented several commonalities in disease concerns, 
especially those around elimination worries, and body image, along with concerns 
about normality when living with IBD. Social support, including support from health 
professionals, was identified as an important aspect that helped when living with this 
disease and several of the studies explored adaptation to living with IBD. 
The lives of those with IBD are affected by their disease symptoms, especially 
with respect to social activities, and they experience a great deal of uncertainty in 
relation to this disease. It also causes such feelings as being controlled by the disease or 
a sense of alienation because of the nature of the disease. 
Food as a coping strategy was a topic of research and explored people with IBD 
and IBS using food or diet changes to aid in controlling their disease. The remainder of 
the qualitative research covered medication use and adherence, along with exploration 
ofthe usefulness of moving to an open-access follow-up style of medical appointments 
for those living with IBD. 
In addition to the qualitative research I reviewed many quantitative research 
studies in this chapter. While all the quantitative research reviewed examined QofL in 
some form, more specifically the quantitative research covered the categories of disease 
impact, coping, and psychosocial functioning. Research on disease impact again shared 
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many commonalities and with some of the qualitative research reviewed in terms of 
identifying disease related concerns. Some disease related concerns common in the 
quantitative studies were around elimination worries, medication side effects, and extra 
intestinal symptoms as impacting QotL for those living with IDD. 
While the studies on coping when living with IDD uncovered some differences, 
overall those using depressive or emotional type coping strategies experience a 
decreased QotL versus those using problem-oriented or optimistic coping strategies. 
Finally, results from the quantitative research that explored the impact of psychosocial 
functioning found that those living with mo who had a decreased psychosocial 
functioning experienced a decreased QofL compared with those who had enhanced 
psychosocial functioning. Overall the review of the literature on IDD, both qualitative 
and quantitative, contributes to an increased understanding of what it is like to live with 
IDD. 
Chapter 3 
Research Methodology 
The descriptive phenomenological methodology of Colaizzi (1978) was selected 
to investigate the experiences of living with inflammatory bowel disease (ffiD), either 
Crohn 's disease (CD) or ulcerative colitis (UC) as a young adult. Phenomenology is 
suited to investigating lived experience from a holistic perspective (Streubert-Speziale 
& Carpenter, 2007). Colaizzi describes his approach as "an understanding-descriptive 
methodology" (p. 58) and since my research objectives were to describe and understand 
the experiences of young adults living with ffiD, I felt this was an appropriate research 
methodology. 
Nurse researchers have used Colaizzi 's (1978) method to study the meaning of 
lived experiences of particular phenomenon, including the experience of chronic illness 
(Michael, 1996). According to Colaizzi, in order to psychologically investigate human 
experience one must choose a method which "neither denies experience nor denigrates 
it or transforms it into operationally defined behavior; it must be a method that remains 
with human experience as it is experienced, one which tries to sustain contact with 
experience as it is given" (p. 53). He further stated that this could best be achieved by 
using the phenomenological approach of description. 
1n phenomenology, the subjective experience ofthe individual is valued and 
respected and the existence of multiple realities is acknowledged (Streubert-Speziale & 
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Carpenter, 2007). Knowledge about the experience is constructed through collaboration 
and interaction between the participant and the researcher. It is the meaning of an 
individual experience that becomes important, not merely the experience itself 
(Colaizzi, 1978). 
A phenomenologist must initiate inquiry with an examination of his/her 
presuppositions about the investigated phenomenon (Colaizzi, 1978). This helps the 
researcher uncover certain beliefs and attitudes that they hold regarding the particular 
phenomenon. To do this and in keeping with the psychological approach of Colaizzi, I 
continuously examined my personal beliefs and assumptions regarding the research 
phenomenon ofliving with IBD. My self-reflection aided in minimizing the influence 
of my personal beliefs during the data collection and analysis, and helped to accurately 
reflect the data gathered (Streubert-Speziale & Carpenter, 2007). 
Bracketing is a term used to describe the process by which a researcher sets 
aside presuppositions on a particular phenomenon (Gearing, 2004). In research practice, 
what the researcher means by the term is not always clear and as Gearing indicates, 
there are a number of different approaches or typologies of what bracketing is. In this 
research the type ofbracketing I used most closely approximates that of"existential 
bracketing" as described by Gearing, i.e ., "hold in abeyance suppositions and theories 
of phenomenon 's lived experience" (p. 1440). I did not review theories of chronic 
illness until after I had completed my data analysis. As well I worked with my 
supervisory committee to compare and discuss my data analysis throughout the study 
and we discussed how my understanding of what I had read, may have influenced my 
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data analysis. Systematically using the data analysis procedure as outlined by Colaizzi 
(1978) also helped in not letting presuppositions have undue influence. 
Participants 
The participants for this study included three young adults between the ages of 
21 and 31 years. In qualitative research the number of participants can include anyone 
who has experience with the phenomenon of interest and can communicate it (Colaizzi , 
1978). I had originally planned to recruit eight to ten participants for the study, but due 
to difficulties in recruitment that are discussed later in the limitations section of the 
study, I was only able to obtain three participants. 
Criteria for participant selection included young adults who were: 1) diagnosed 
and living with ffiD (either CD or UC) for a minimum of one year and did not have an 
ostomy; 2) between the ages of 19 and 29 years; and 4) able to speak, read and write 
English, as language is important to the data collection and analysis. 
Participants with either CD or UC were targeted for the research study. 
Although I recognized these were different conditions, one could expect similarities in 
their lived experience. Both conditions often require the same treatments and share 
many of the same symptoms and complications. I recognize that most literature 
suggested CD affects a person's life more profoundly than UC, due to greater symptom 
severity for those with CD (Drossman et al., 1989; Dudley-Brown, 2002), however, 
research and self-help books investigate and combine both conditions more often then 
not (Sabil, 2003 ; Smolen & Topp, 1998). 
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When I was in the design phase ofthe study and examining the feasibility of 
recruitment, I discussed my proposed study with a local gastroenterologist, and he 
suggested that I interview participants who had a confirmed diagnosis and some time to 
get used to the idea of having the condition. I agreed with this suggestion as I felt that 
individuals who were newly diagnosed with ffiD would have very different experiences 
from individuals who had been living with the condition for some time, so I had as a 
criterion that participants have been living with this condition for a minimum of one 
year. Using the same reasoning I did not include individuals with an ostomy. 
Individuals with an ostomy have greater problems with body image and concerns about 
clothing than those who have not had an ostomy (Simmons, Smith, Bobb, & Liles, 
2007). My recruitment strategy was not to negate the experiences of those newly 
diagnosed, nor of those who had an ostomy. I also felt that because I had consulted the 
gastroenterologist and would be somewhat dependent on his office for recruitment that 
I would take into account his advice. Both research ethics boards and physicians can act 
as powerful gatekeepers for "clinical populations" such as individuals diagnosed with 
ffiD and collaboration is suggested as one strategy for recruitment (Bond Sutton, Erien , 
Glad, & Siminoff, 2003). 
In an attempt to capture what it was like to be a young adult living with ffiD, I 
decided that the ages from 19 to 29 years most accurately reflected the young adult 
population. During the study due to difficulties in acquiring participants I reevaluated 
this criterion and included anyone who volunteered up to the age of 31 years as long as 
the participant had experienced this condition as a younger adult and met the other 
inclusion criteria. 
Recrnitment of Participants 
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Participants for the study were recruited with the help of either local 
gastroenterologists or nurses who conduct clinics or work in endoscopy units operated 
through Eastern Health, Newfoundland and Labrador, Canada I contacted these 
physicians and nurses with information regarding the study and a request to assist me in 
acquiring participants (see Appendix A). If they agreed to help with recruitment, 
physicians and/or nurses would present potential participants who met the inclusion 
criteria with a brief one-page information sheet (see Appendix B) about the study, at 
which time potential participants could agree to provide their name and contact 
information to me. The initial information sheet given to potential participants by their 
physician/nurse included general information about the study as well as information on 
the participant selection criteria and measures used to maintain a participant's 
confidentiality. Those young adults who were interested in receiving more information 
on the study had the opportunity to provide their name and contact information, which 
was then passed onto me by the physician/nurse. Upon receiving any contact 
information, I called the potential participant to provide them with further information 
about the study, answered questions they may have had, ensured they met eligibility 
criteria, and determined whether they were interested in participating in the study. At 
the beginning of the first interview, the participants formally consented to participate in 
the study and have their interview audio-taped by signing the consent form (see 
Appendix C). 
Setting 
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In determining the appropriate setting for the interview I allowed each 
participant to choose a place where she would feel most comfortable for data collection. 
I offered the option of going to the person 's home or arranging a private office in the 
Health Sciences Centre. Two of the participants chose a private seminar room in the 
Health Sciences, and one because of the nature ofher job and the necessity of frequent 
travel, asked to have her interview conducted by telephone. Both participants who 
chose to come to the Health Sciences Centre were familiar with the hospital and clinic 
part of this building so locating and accessing the centre was not problematic. The 
main reason given for the choice of setting was the privacy that it afforded, and that the 
participant would be away from family members, when she talked about her condition. 
I ensured that the setting for all three interviews was both comfortable and 
private, and validated that this was so with each participant, prior to beginning the 
interview. I also checked with each participant throughout the interview to ensure she 
continued to feel comfortable and that her privacy was being maintained. This was 
particularly important for the participant being interviewed by telephone because I was 
unable to see any cues that might indicate discomfort. 
Data Collection 
Colaizzi (1978) described different "methods", i.e., written sources, dialogal 
interviews, and observations as all means of gathering descriptive data to understand 
------- ------ ---------------------------
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the phenomenon of interest. I selected an interview as the method best suited to my 
research study and a means of capturing the young adult's experiences with IBD. ln 
particular Colaizzi suggested an un-structured interview. This type of interview that 
often takes the form of a dialogue between a participant and the researcher is more 
likely than a question and answer approach, to help the persons engaged in the 
conversation to be on an equal level and to establish trust (Colaizzi). I facilitated the 
participants ' descriptions of their lived experience by using open-ended, clarifying 
questions if needed (see Appendix D). In most instances this was not required as 
participants talked freely about their experiences. Using an open-ended approach for 
my interviews allowed me to follow the participant's leads but gave me some needed 
guidance if the participant required a prompt. I began the interview by asking the 
participant " to tell me what it was like to live with IBD" and ended when the participant 
felt she had fully described her lived experience. Each initial interview lasted 
approximately one hour. 
Although participants were informed in their consent forms that two interviews 
would be required, only one interview was tape-recorded with each participant. The 
intent of the second interview was to obtain any clarification from the first interview 
and of the theme clusters and initial interpretation I had made. When I contacted the 
participants by telephone and described to them my initial analysis of the data, none of 
them said that they had any new information to add so a second interview was not 
needed. 
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The interviews, in keeping with what Colaizzi (1978) suggested, were audio-
taped and then transcribed verbatim. In addition, I made some written notes 
immediately following the interview, as well as engaging injoumaling of thoughts and 
changing assumptions. These thoughts and notes were included in the data analysis. 
Data Analysis 
Colaizzi (1978) outlined a set of procedural steps to assist with data analysis 
and interpretation and suggested that these steps "are by no means definitive" and that 
the steps "be viewed flexibly and freely by each researcher" (p . 59). As a new 
researcher I used these steps as closely as possible as my guide for data analysis and 
interpretation. These steps summarized from Colaizzi's description (pp . 59-62) 
[where italicized it is because italics are used in the original] are: 
1. Carefully read each transcribed interview to both develop a feeling for and a sense 
ofthe data; 
2. Extract significant statements from the data based on the phenomenon investigated; 
3. Formulate meaning for each of the significant statements identified; 
4. Take the formulated meanings and put into clusters of themes; and 
5. Integrate the significant statements, formulated meanings, and themes into an 
exhaustive description of the phenomenon. 
In keeping with phenomenology as described by Colaizzi (1978) following data 
collection and transcription, I began the analysis of the data by reading the interview 
texts to identify significant statements of what it was like to live with IBD. Next I tried 
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to identifY the meaning of each significant statement. Meanings were formulated for 
each statement identified. I then organized similar formalized meanings into clusters of 
themes. Table 1 (see Appendix E) is an example of how I took significant statements 
about treatment, formulated meanings from these statements, and clustered these 
meanings into a theme. My written interpretation of each description was validated by 
multiple re-readings of the data and was supported by the use of direct quotations. This 
interpretation was further validated by review of the descriptions with my supervisory 
committee members. I then returned to the participants for validation of the descriptions 
and of my interpretations. While there was no new data during the validation phase, 
some clarification and affirmation of the themes was obtained, and incorporated into the 
exhaustive description of each of the identified themes. 
During the data analysis process I reviewed previous journal notations, 
thoughts, and emerging themes and continued to engage in these activities. I continued 
to identifY any presuppositions I had about the phenomenon being studied and in the 
final analysis my description of themes was directly supported through the use of direct 
quotes from the participants. 
Validation 
When considering the quality of phenomenological research it is important to 
note that this methodology should be measured against itself and whether it has 
accomplished its goal of describing the experience (Colaizzi, 1978). To accomplish 
this Colaizzi suggested a number of steps that he incorporated into his procedural steps 
associated with data analysis and that he termed "validation". 
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The first attempt at validation occurs when the formulated meanings are 
clustered into themes. It is crucial at this time to take the themes and check them 
against the original data to see if any important information in the original data is not 
accounted for in the themes or if the themes go beyond what is represented in the data. 
This step was carried out in conjunction with meetings held with my supervisory 
committee members. We independently worked through the steps of data analysis and 
discussed our conclusions. 
A second means of validation suggested by Colaizzi (1978) is to take the 
findings, once you have validated them in the step just described, and return to the 
participants in order to establish if your descriptions compare with their experiences. 
This can occur through a second interview or if needed a series of interviews and any 
new information must be incorporated into the final description. Following thematic 
analysis I provided each participant with a brief description of my themes via a follow-
up telephone call . At this stage no new information was added and participants felt it 
had captured their experiences. Thus the women who took part in this study validated 
my findings . 
This process of validation I used is similar to one of the means of establishing 
credibility that was suggested by Lincoln and Guba (1985). They identified this process 
as " member checks", and further described it as a means "whereby data, analytic 
categories, interpretations, and conclusions are tested with members ofthose stake 
holding groups from whom the data was [sic] originally collected" (p. 314). Ofthe 
means of establishing credibility outlined by Lincoln and Guba, they suggested member 
40 
checks were the most important. 
Ethical Considerations 
For research to be accepted by other scholars, practitioners, and the general 
public, it must not only be rigorous but must also meet the appropriate ethical 
standards. These ethical standards are specified and monitored through institutional 
research ethics boards (REBs}, and these REBs in Canadian institutions adhere to the 
Tri-Council Policy Statement Regarding Ethical Conduct for Research Involving 
Humans (2005) generally referred to as the Tri Council Policy Statement. Prior to 
beginning my research, my proposal was submitted to, reviewed by, and approved by 
Memorial University 's REB, the Human Investigation Committee (HIC) and continued 
approval was obtained throughout the research (see Appendix F). IDC monitors 
research on an annual basis to ensure the researcher adheres to the recruitment 
strategies and data collection as approved. It also requires the researcher to report any 
adverse effects ofthe research. 
The IDC approved my planned recruitment of participants. The plan approved 
was asking local gastroenterologists or nurses who conduct clinics or work in 
endoscopy units operated through Eastern Health, Newfoundland and Labrador, Canada 
to distribute letters to patients who met the inclusion criteria Eastern Health gave 
permission for me to approach these employees to assist with recruitment These steps 
were necessary to protect confidentiality of patient information, i.e., not disclosing 
patient names and contact information to me without the patient's permission, as well 
as to ensure I did not put any pressure on patients to participate in my research by 
approaching them directly. 
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Prior to my data collection I obtained infonned consent and infonned 
participants of their rights and any potential risks. When conducting research involving 
humans it is important that participants are fully aware of their rights and any risks to 
them in participating in the research. During an initial meeting with each participant, I 
discussed the purpose of the study, how confidentiality would be maintained, the right 
of each participant to refuse to answer any question, and the right to withdraw from the 
study at any time without influencing current or future care. The interview process was 
explained to the participant, and permission to be interviewed took place with the 
signing of the consent fonn (see Appendix C). 
Although participation in the research may not benefit the participant directly, 
the participants had the unique experience of sharing their lived experience with IBD. 
When considering risks to the participants I discussed with them that participation in 
the research could result in their experiencing emotional distress, during or following 
the interview, as a consequence of sharing this experience. The potential risk of 
experiencing emotional distress during and following the interview was also identified 
in the consent fonn. I had agreed to help identify if support would be beneficial, and if 
necessary, would have provided the participant with a name and telephone number of a 
prearranged support person. No participant expressed that she experienced distress nor 
did any request or require the need of a support person. All participants were receiving 
ongoing care and support from physicians and other health care professionals so they 
would have access to care when needed. 
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Maintenance of confidentiality was also part of my ethical approval . Each 
participant was told that personal identifying information would not be shared with 
others and that interview tapes would be returned to participants (if desired) or 
destroyed 10 years following completion ofthe study. Real names of participants did 
not appear on any transcriptions, on audiotape labels, on computer disks labels, 
computer storage devices, on any written notes, or in presentations of the study in order 
to keep the information provided confidential . Tapes, transcriptions, and notes were 
kept under lock and key at my home and were accessible only by me. I was the only 
person who knew the identity of the participants. The participants were informed that a 
transcriber would be used and it may be possible that participants' voices may be 
recognized. Transcribers were asked to take a verbal oath of confidentiality. Members 
of my supervisory committee were given transcribed interviews, but not given any 
identifying data relating to the participants. 
Summary 
A descriptive phenomenological approach as outlined by Colaizzi ( 1978) was 
used to guide the study. Three young adult women who were diagnosed and living with 
IBD were recruited for this study. These participants met set criteria and selection 
procedures. Data collection involved conducting and transcribing unstructured, open-
ended interviews. Colaizzi's steps of data analysis were used to identify clusters of 
themes and to develop a description of the phenomenon. Validation and ethical 
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considerations were continually addressed throughout the research process. 
Chapter 4 
Findings 
What is it like to live with Inflammatory Bowel Disease (IBD)? How djd the 
women in the study experience living with IDD? This chapter presents an overview of 
the findings of what it was like for these three women to live with IBD. While each 
woman 's experience was unique, all three had similar experiences and feelings 
regarding what it was like to be a young adult living with ffiD. Seven common clusters 
of themes were identified from the data, and the themes, together with a description of 
these themes, is presented in this chapter. While the overall theme was true for each of 
the women, there were both similarities and differences in their perceptions and lived 
expenences. 
The seven themes that came from the women' s experiences were as follows : (1) 
dealing with symptoms: a constant struggle; (2) embarrassment: trying to hide this 
condition; (3) uncertainty: it could flare up at anytime; (4) lost time: interfering with 
normal life; (5) the double edged sword: treatment can be as difficult as the rusease; (6) 
needing to maintain a supportive environment; and (7) accepting the challenge of living 
with ffiD. While these themes are presented separately, in combination they best 
describe the experience of these women. 
The Women 
The participants consisted of three women; two were diagnosed with Crohn 's 
disease (CD) and one with ulcerative colitis (UC). The first woman was 22 years of age 
and had been living with CD for approximately two years. She had several 
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exacerbation/remission cycles since her diagnosis and was currently experiencing an 
exacerbation of symptoms and taking the medication Prednisone. The second woman 
was 28 years old and had been diagnosed with CD at age 20. She too had experienced 
many up and downs in gaining successful control of her symptoms, and was currently 
maintaining a remission of symptoms by taking the medication Imuran. The third 
woman was 31 years old and had been diagnosed with UC as a teenager. Like the 
others, she had experienced many ups and downs in the course of her disease 
experience and at the time of the interview was maintaining a remission by taking the 
medication Methotrexate. Each of the women was employed, and was either married or 
in a committed relationship. None of the women interviewed had children . Each was 
followed long term by a local gastroenterologist and all were recent patients of one of 
two endoscopy units within Eastern Health, Newfoundland and Labrador, Canada. 
The Experience of living with IBD 
Dealing with Symptoms: A Constant StnJggle 
Symptom experience was a large part of what it was like to live with ffiD. In 
fact having experiences around symptoms, like not being able to eat because "of pain in 
my stomach and diarrhea" and having no energy because "!was just losing blood every 
day", largely defined many periods of these women 's lives. This theme was 
predominant because of just how much the physical symptoms offfiD dominated much 
oftheir lives. There were a number of significant statements from the interviews that 
were clustered under this theme. Dealing with the struggle of managing disease 
symptoms had a big impact on daily life. All three participants described the struggle 
~ -
they had with what they considered devastating symptoms when their disease was 
exacerbated: 
When you 're in the middle of a flare-up, you're not sick all day 
long, you 'refine for like .five hours, and [then]you could have a 
three hour stretch kneeling over in pain with cramps and using 
the washroom twenty times. 
I was so young, then I'd come home then and I'd be up all night 
going to the bathroom. I was eating but, I couldn't eat, every 
time I'd eat I 'd go to the bathroom. I lost a lot of weight when I 
got sick 
By this point my eyes were foil of big red blotches -comes with 
rohn 's - my mouth was coated with sores. I was pale, I was 
underweight and I couldn 't stand up by myself for very long 
periods of time at all. 
The experience of symptoms was pretty well a constant, because whether they 
had an exacerbation or were in remission, they still had some symptoms they had to 
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face. The only thing that distinguished the symptoms of exacerbation and remission was 
that they were of a different nature. An exacerbation meant that it was a symptom of the 
disease while during remission the symptom was as a result of being on long-term 
medication. These differing symptoms both presented a number of physical difficulties 
and challenges for each of the women. During an exacerbation they were physically 
exhausted and weak from the pain, diarrhea, and not eating; each a characteristic of the 
disease. These disease symptoms were at times quite debilitating and always an 
intrusion in their lives: 
So every time you eat something you are going to the bathroom 
and you're dying in pain right? You can't go anywhere. It 's 
definitely not nice. 
I had no energy because I was just losing blood everyday. I was 
kneeling over with pain on the couch because I had such bad 
cramps. 
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Diarrhea and a constant feeling of urgency to have a bowel movement meant that 
the women always had to be near a bathroom. Dealing with frequent bathroom trips 
was bad enough, but the diarrhea was associated with severe pain, " it was like labour," 
and dealing with the pain took a real toll. For some the urgency and need to have a 
bowel movement was one of the most unpleasant of all the symptoms they had: 
Anything, everything about using the bathroom was not normal 
and (was] painful and frequent, like five or six times a day. 
I mean I had times where I 've been fine the whole day and I woke 
up in the middle of the night ... I've actually woke [sic] up out of 
my sleep to go to the washroom numerous times. 
Having a remission did give them some respite from the actual symptoms of 
ffiD and this respite was welcome, but because of the nature of the medications it did 
not mean that they were symptom free. It just meant they had different symptoms to 
deal with, because during periods of remission, they had to deal with the side effects of 
their long-term medications as a daily struggle. These side effects produced a wide 
array of physical symptoms such as fluid retention and bloating, joint soreness, and 
headaches. In addition to the unpleasant bodily feelings associated with the physical 
symptoms, they felt self-conscious about these highly visible physical symptoms. 
Like one was Prednisone and I gained twenty pounds from all the 
fluid and stuff on the drugs. !found that quite bad, like I didn 't 
want to go anywhere. All my face was covered in acne; all side 
effects from the drug. So !found that really hard. It pretty much 
changed your -you know, changed your appearance, and you are 
also physically in pain. 
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For the women, life while taking corticosteroids (the hallmark of treatment for an acute 
exacerbation ofiBD) was often just as challenging as dealing with the disease 
symptoms: 
When you 're on high doses of Prednisone your face looks like it 
gained thirty pounds and nobody understands. 'Oh she's gained 
weight you know ". Nobody understands why you look so big. 
That 's really hard to deal with. 
Embarrassment: Trying to Hide the Condition 
Feelings ofembarrassmentpermea.ted much ofthese women 's experiences and 
began when they first started having disease symptoms. When they talked about IBD 
they either prefaced some of their comments by saying some incident was 
embarrassing, or after they related a particular event they told me it was embarrassing 
or they were embarrassed. Much of this embarrassment stemmed from uncontrollable 
bowel symptoms that left them in socially abnormal or awkward situations. 
I can remember walking into my university class and all of a 
sudden, with no warning, I used the bathroom right there in my 
pants. I mean extreme embarrassment and not knowing what to 
do and not knowing why this is happening. 
One ofthe strategies they used to cope with their embarrassment was to try and 
hide any manifestation of their disease, such as diarrhea and incontinence, because 
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these symptoms were the most embarrassing of all their symptoms. In relating some of 
their more embarrassing situations with ffiD, the women described their frequent trips 
to the bathroom as something they felt they just had to hide, because they djd not want 
their friends to know about "always having to go to the bathroom". It was particularly 
bad when they were growing up: 
When you 're growing up all your friends- oh that 's [diarrhea] 
gross you know- and you 're younger you know, and it 's just that 
you have to hide everything. You still have to hide some stuff 
from people, you know. 
These feelings of embarrassment when they were growing up also prevented at 
least one woman to try and hide her djsease. She told me about the first time she 
noticed her symptoms, and how it was really the embarrassment that prevented her 
from telling her mother about what she was noticing: 
I was having a bit of blood. I just thought that could be a broken 
blood vessel or fissure and I didn 't think much of it. Obviously 
being that age you don 't run to your mom right away and say I 
have blood, it 's kind of embarrassing. 
When the women were traveling, or out, or in public places, they were often 
worried about what would happen. Wbjle all of the participants experienced urgency 
and occasional fecal incontinence, one woman in particular described feeling extremely 
embarrassed over a situation of incontinence. This woman described how terrible it was 
to experience this fecal incontinence in a public situation : 
[when] I've got to go[to the bathroom], I 'lljustpanic and we 'II 
try to rush to the nearest bathroom. I've had accident before 
and that part is really bad. - [Once] there was no bathroom and 
I just couldn 't hold it so I went in my clothes. I had to get out and 
go into the bathroom and wash my clothes. It was just very 
embarrassing. 
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Part of the embarrassment stemmed from others knowing about their situation, 
or just talking about bodily functions, especially bowel movements, which they 
considered as "socially taboo" . These women did not consider it acceptable to discuss 
their disease symptoms, other than in health care interactions and used words in thei r 
interviews such as "too graphic" or "gross," as to why it was not acceptable for 
discussion . It was because of their feelings on this topic, that it was a constant battle to 
hide the nature of their bowel movements and frequent trips to the bathroom. When 
further expressing the "socially taboo" nature of the disease, participants described not 
only hiding the physical manifestations, but also not wanting to talk about their disease 
with others: 
I'm kind of thinking it 's because of the type of disease it is and 
people don 't want [you] to describe it. 
Just as they felt the need to hide their symptoms and not let others know, they 
also felt a need to hide the associated treatments. Using such treatments as medication 
enemas increased feelings of embarrassment: 
1 take enemas every night as well, I mean that 's prefLy hard to 
you know hide. You know I stick something up my ass you know-
it 's kind of you know - I don 't mean to be vulgar about it but, 
how do you explain that to somebody. 1 mean you can 't explain 
that to somebody who 's immature that 's for sure. You have to 
you know- I mean you 're constantly hiding things right and it 's 
just embarrassing sometimes. 
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The "bowel" symptoms of the disease and associated treatments made it 
different from other chronic diseases and less acceptable to share any aspects of thei r 
disease with others. As IBD is a bowel djsease that causes such things as gas, 
abdominal cramps, and diarrhea, it was difficult to share this information with others. It 
is often a hidden disease in that unless the women shared their symptoms with others, 
nobody knew. The women felt that ffiD is not talked about regularly nor publicized as 
much as other chronic diseases. They said they felt that ffiD is both less acceptable to 
talk about and not easy to discuss because of the embarrassment it causes: 
Like I can picture them saying "oh I'm a diabetic ", but! can't 
picture them saying that they have this [UC]. 
Crohn 'scan be an embarrassing disease, it 's a bowel disease. I 
didn 't want everybody and their brother knowing that I'm there 
with dian·hea and all this different stuff 
It is one thing to discuss fluctuations in blood sugars, but another thing to 
discuss diarrhea. The latter was much less socially acceptable. All women in the study 
expressed many feelings of embarrassment when it came to living with ffiD . The 
physical aspects of the djsease contributed to their feelings of needing to hide their 
disease from others and feelings of embarrassment in social situations. 
Uncertainty: It Could Flare up at Anytime 
The fact that ffiD is characterized by exacerbations and remissions and that these 
events are marked by an element of unpredictability contributed to a feeling of a lack of 
control, and this lack of control resulted in feelings of uncertainty. The women 
described how the uncertainty surroundjng their illness affected both their day-to-day 
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coping as well as any plans for the future. It was the feelings of uncertainty around what 
may occur in either the course of their disease or their lives that marked many of the 
significant statements in the interviews and that are included under this theme. One 
woman described the uncertainty and unpredictability of her disease exacerbations as 
being both irritating and emotionally draining: 
You know, just basically trying Jo maintain [disease remission] is 
the hardest part, it kind of creeps up on you. It 's like a cold, 
you ·refine for a year and you almost forget you have it, and then 
you look in the toilet one day and you go "oh great ". It 's just 
irritating at some point, and it gets you down emotionally that 's 
for sure. 
This same woman, who was dealing with a recent exacerbation at the time of the 
interview, expressed frustration and illustrated the impact that seeing the symptoms 
return again engendered. It is that "one day" when you notice the signs that the disease 
has returned that you feel let down, even though you are aware of the chronic nature of 
the condition: 
It was so disappointing when I started again a couple of weeks 
ago. Oh my God I was devastated. I was devastated. It's like a 
flu that you can't get rid of you know, it 's just devastating when 
you- everything is going .fine you know- everything in my life 
was perfect you know- and I mean I just went to the washroom 
one day and I saw blood again, and like I hadn 't seen this in ages 
and you know it really startles you, and upsets you at .first. 
The return of symptoms after a period of remission could come as a shock and 
certainly a disappointment. It was the suddenness of the symptoms returning that 
bothered the women. One day they were free of disease symptoms, but then the 
symptoms appeared again, and once more their lives were disrupted in so many ways. It 
really changed any plans they had made and often left them feeling helpless. One 
woman further expressed frustration surrounding the chronic exacerbation/remission 
associated with the disease as well as the changing nature: 
It 's like you 're a normal person you know, until boom one day-
Its funny it 's just one day it comes on you -it 's not so much 
gradual, you know. It was when I first got diagnosed, but now it 
comes on with a vengeance. 
This uncertainty influenced how the women monitored their bodies for the 
return of symptoms, or thoughts of how they would meet expectations of work and 
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social life. Often at the backs ofthe women's minds and pre-occupying many of their 
thoughts, either upon waking or going to sleep at night, was the uncertainty of if they 
would once again have symptoms. This uncertainty could mark going to bed or getting 
up in the morning: 
I 'm constantly thinking am I going to wake up and not be able to 
go to work today because I have such bad cramps. 
Exacerbation of symptoms was unpredictable and uncertain . How this 
uncertainty could affect employment, school, and other responsibilities was something 
they thought about often. The same woman just quoted when discussing her disease and 
employment, further expressed the frustration of the unpredictability of her disease and 
how difficult it is to deal with when it comes to work : 
Every lime I use the washroom and have cramps, I can '1 give you 
a doctor 's note. It 's a symptom of my medical condition, you 
know what I 'm saying, it 's not like I have strep throat and I can 
go to the doctor and get a doctor 's note. And like they 're 
employers, it 's a big thing to explain to your employers if it 's a 
problem. Some people don 't understand. I don 't think there 's 
enough awareness out there because some people don 't even 
know what it is- a lot of people. 
She felt it was important for her employer to understand her disease and the 
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uncertainties she faced. She furthered felt that her chronic illness was different from an 
acute illness and needed to be considered as such. This woman felt that if her employer 
had a better understanding it would translate into greater feelings of support when it 
came to dealing with her disease and her employment situation. 
The feelings of uncertainty and frustration that the women felt, often led to 
expressions of anger and resentment. One participant described the uncertainty of her 
disease in a statement that expressed her emotional fluctuations between it's the worst 
disease and it could be a lot worse: 
Yeah your just on edge you know, you 're just, so mad but yet you 
have to think okay at least I don 't have diabetes or something 
you know, you almost f eel selfish, but at the same time you 're like 
it 's not fair, you know. 
Lost time: Jnterforing with a Normal Life 
Having ffiD placed a number of restrictions on these women 's lives, because of 
their symptoms and the unpredictability of the course of the disease, as well as 
uncertainty of when it would flare-up again . It was both the unpredictability and 
uncertainty that interfered with a sense of normalcy and interfered with leading a 
normal life. This theme centered on losing time with friends, educational opportunities, 
or more recently work and starting a family. 
------------------------------------------------ - ---
I got diagnosed in the summer and I was starting college in 
the fall, so I start, but by December I was so sick that I had to 
quit. So I had to give up school. !found that really bad. 
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The women described a number of examples of how living with ffiD interfered 
with what they would consider a normal life. This theme was particularly prominent 
and was much more difficult when they were younger. They missed out on many 
experiences and activities with their friends ; experiences they considered part of normal 
activities and growing up. Participants described how living with ffiD and its 
restrictions had changed their lives: 
I guess I'm always on guard a bit. !found getting ulcerative 
colitis took away my youth a bit. I definitely found that. You know 
how when you 're nineteen or early twenties it 's suppose to be the 
best time of your life. I didn t have that. I definitely didn 't have 
that. That was the worse time in my life. 
It 's changed my life because there 's a lot of things I can 't do. I 
was only young when I got it so like, there's different things I still 
won 't do. I won 't go camping or stuff like that like, you know. I 
always want to be near a bathroom. 
Youth is usually a time filled with many social activities and a time that most 
adults look back on and remember feeling fairly carefree. Youth had been diffe rent for 
these women. They didn ' t feel carefree; instead ffiD disrupted and restricted their lives. 
It caused them to miss out on many adventures and opportunities that youth offered; a 
sense of lost time. They noted that usually teens do not have to worry about being near 
a washroom or tum down activities for fear of not having washroom faciliti es, but these 
worries were a reality and they felt a need to be near a bathroom almost all the time: 
If we're going away, I have to know where the bathroom is, and I 
always prefer my own bathroom because it makes me nervous 
when there 's no bathroom around because when you got to go. 
you got to go. 
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All three of the women described this same reliance on being near a washroom, 
and one participant said how this interference in her life was one of the most difficult 
things for her to deal with: 
You are not comfortable unless you know where the washroom is 
in a building, and high school, going to cabin parties. I 'd never 
go you know. Just because sometimes you don 't have a 
washroom that's working you know. There's little things like that 
!find the hardest part to deal with. 
Another participant described her reliance on a being near a toilet as an absolute 
necessity, even though she knew this reliance limited where she could go and what she 
could do. In fact, when she had a flare up of symptoms, a toilet for her was a safe 
haven. Being near a bathroom was reassuring and made her feel safe. It offered 
protection, a sense of feeling better just because she knew she had a safety net nearby : 
Going on road trips with your friends and stuff like that, I mean 
you can 't go because you know you 're sick. You can 't be not 
near a toilet. It 's like sometimes you have cramps, you don 't need 
to use the washroom, you sit on the toilet and it makes you feel 
better. It 's weird. It 's like a sanctuary. 
Living with ffiD interfered with how they actually lived their lives; imposing a 
number of restrictions on them. These restrictions could at times lead to social isolation. 
One woman in particular voiced this isolation and the huge emotional toll it took on 
her. 
Sometimes you just break down, like cry, because you 're so 
frustrated you know. You can't go out on a Friday night and 
drink unti/4: 30am like everyone else because you can 't get sick. 
you know, youjustfeelleft out sometimes. You can 't do things 
with other people or you just get frustrated because you 're on 
this medication. And you wake up after you just finished your 
trial of medication and there's blood again. You knol't', you cry. 
You break down. For someone to say, and hug you and tell you 
it 's fine and understand you know, "Are you okay? ", it 's nice for 
someone to ask if you 're okay. You know it 's nice like that. 
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For the two married women in the study the desire to become pregnant and start 
a family was prominent, but due to limitations their disease and its treatments placed on 
the possibility of motherhood they had to deal with this perceived loss. It was another 
form of " lost time" in that their childbearing years were affected. Not only did these 
women have to deal with the disease and treatment symptoms, they also had to cope 
with the loss of not being able to get pregnant as a result of their disease and its 
treatments. 
That 's a really big thing like that because I have this disease. They told 
me that when I got ulcerative colitis, actually that was one of the .first 
things that they said that it might affect the ability to have kids. They did 
tell me that. 
Actually I did mention it because of the other thing. I'll tell you one 
thing that 's really changed my life from it, is that I can 't have kids. 
IBD actually interfered with their ability to start a family or even to entertain the 
possibility of a pregnancy. As young adults this was one of the major influences that the 
disease had on their lives. For these women this was a devastating loss. 
You can't get pregnant on Methotrexate. Right? So that 's one very 
devastating thing for me. 
Every time I come off it [medication] I get sick and they just really don 't 
recommend me trying to carry a baby . That 's probably the biggest thing 
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in my life that is bothering me about it. So all the decisions around 
pregnancy, like we've always kind of felt cheated because young people 
in a new relationship, if they want to, if they feel they are in a permanent 
relationship and they want to be you know have sex and not be protected 
then that's okay if they get pregnant. We can 't do that. We don 't have 
that option of being unprotected. 
Although they experienced not having a baby as a loss, they also described how 
they had come to terms with it as a couple, but frequently they found themselves in 
situations where they were reminded of the fact that they could not have a baby. 
You know what I mean like there 's so many questions? We are okay 
with that, we are in our own place, we 're looking at different aspects of 
adoption, how that would work. We still have that pressure every day 
and from people who don 't know us, people at work. I was sick a couple 
of mornings, my Crohn 's kind of acted up a little bit and I was dizzy, 
nauseous and that kind of stuff and I had to take two days off of work. 
Everybody was like, "Oh it sounds like morning sickness; you 're 
pregnant aren 't you? " It 's a daily reminder. There 's three people 
pregnant in my office right now and they 're like, "Oh it 's soon you 're 
turn. " I'm like yes but it 's so complicated. 
The Double Edged Sword: Treatment can be as Difficult as the Disease 
Effective treatment is absolutely necessary to control symptoms of ffiD and 
effect remission of the symptoms ofthis disease condition. The women certainly 
recognized this fact and talked about their treatment as they discussed living with ffiD. 
This theme addresses both the acknowledgement of the need for medication and the 
concern over taking the medication. Benefit and risk was usually contained in all the 
statements on medication: 
Well he [physician]put me on steroids. First of all, 
Prednisone, obviously it 's a pretty risky drug. So he put me on 
I think probably the highest available dose for somebody of 
my age and weight or tolerance. But I remember after the first 
pill it was like a miracle drng. Like I probably cut down using 
the washroom - probably five times that day, you know. 
because it worked so well. 
The women took their prescribed medication because they felt they did not 
have much choice in the matter. They recognized that you either take medication or 
you have to suffer the consequences of an exacerbation. So while they clearly 
understood the need for medication, they also understood the risks associated with 
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taking these and this could create a serious concern. Being on some of the medications 
prescribed also meant some invasive monitoring to see what effects it had on other 
body organs: 
I still have a lot of worries with the Methotrexate because I have 
my blood checked regularly. I have to have liver biopsies done. 
There are a lot of side effects with the Methotrexate. They told 
me like in ten years I 've got an increase chance of getting cancer 
from the drng, right? I don 'I have any life, like as long as I stay 
on that drng I'm stabilized but as soon as I start weaning myself 
off, 1 start getting sick I really don 't have much of a choice 
right? 1 do worry about that because it 's such a strong drng and 
I 've been on it so long and 1 was so young when 1 went on it. I do 
worry about that, everyday 1 worry about that. 
Even though the women experienced a number of side effects, particularly in the 
case of steroids, with weight gain and retention of fluids, all the women admitted that it 
was the treatment that made their IBD symptoms bearable. After recalling a time when 
she received an intravenous treatment of steroids one woman described the drug as 
amazmg: 
The next morning my eyes were cleared up and my mouth was 
cleared up. 1 couldn 't believe it. it was amazing. 
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In an attempt to control disease symptoms, after numerous drugs failed to aid in 
maintaining disease remissions two of the women were taking drugs that altered their 
immune systems. They were worried about some of the serious side effects, but it was a 
trade off between having effective treatment that would control symptoms and having a 
more normal life, yet they were concerned about other health effects in the future. 
Sometimes too, the drugs were often a case of trial and error. One woman discussed a 
trial with Imuran and the impact it has on her health: 
I tried one drug Imuran and I wasn't really getting any better. 
but they told me that drugs take about three months to work. It 
suppresses your immune system. I had to be hospitalized and I 
found out that it actually inflamed my pancreas. So I had to stop 
taking that one, they are very potent drugs. They are not nice 
drugs at all. 
Even though the various medications that were used to treat their disease 
produced worry and altered their body image, they also recognized that taking these 
were necessary adaptations they had to make in order to live with IDD - the use of 
medications truly was a double-edged sword. One of the desires that the women 
expressed was for some medication that would work and not have some of the serious 
side effects associated with most of the current treatment: 
The Prednisone is so serious you can't just take it, you know. 
That's the last resort usually - they {physicians J usually hesitate- I 
hate it when I go in, when I 'm sick and they just say "let 's try this 
for another little awhile". I need to be better now, you know. I 
wish there was a drug out there that would fix it. 
Needing to Maintain a Supportive Environment 
This theme arose from the participants sharing their experiences with 
disclosing their illness to others and the supportive or non-supportive reactions 
they received. It also captures how important supportive people and 
environments were to them. All of the women were currently in supportive 
relationships with a partner and they discussed how ffiD had either affected their 
relationship with the partner or one of the hardest things was how do you tell 
your boyfriend about this disease. One woman because of a previous negative 
reaction when dating decided an indirect approach was better: 
I went on the Internet and all I did was basically print off, 
basically an idiot explanation for colitis. So what is colitis, what 
happens when you have it, what are the options? He just read it 
and then he said, " ok, I understand", you know, and he thought 
back, I remember you talking about that or I remember symptoms 
or whatever you know. 
For this particular woman it was easier to use written material then trying to 
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explain or talk about her disease. Once her boyfriend had read the material the lines of 
communication were open and it enabled them to discuss her specific experience in a 
more open manner. Another woman found telling people about her disease was easier if 
they shared a similar experience to hers: 
Anyway, I have told a f ew people, because there 's a co-worker 
who has colitis, she was off work for a long time really sick. 
She 's got issues with pregnancy and she's on Imuran and she 
shared that, so I shared it [my experience] back with her. 
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While the women described being more comfortable telling others about their 
disease and experiences now that they had developed more comfort around the topic, 
they also realized that others could possibly not feel this comfort. As a result some 
expressed ambivalence towards sharing with others because of the nature ofthe disease 
and how some people may react: 
So sometimes I fee/like oh it 'sjust Crohn 's no big deal, right, 
don 't worry about it, if they ask. You know I'm much more 
comfortable with it now but I know that other people might not 
be, so I try and minimize as much as I can. 
At times they did feel that others just would not, or maybe, could not understand 
their disease. These women often felt that volunteering information about their disease 
was not always desirable. For one woman telling others about her disease was 
something she did very little of and only then when she felt she had to tell them. It was 
usually a response to a question or perhaps a needed explanation rather than 
volunteering any information. 
It's not something that I talk about a whole lot, right? Unless I 
got to or whatever- if someone asked me I would tell them. 
While the women had mixed feelings around their desire to share with others 
their experience ofliving with ffiD, in certain situations they felt it was sometimes 
necessary, regardless of the fact that it was often difficult to share this information with 
others. The women often felt that others could never understand what it was truly like 
to live with ffiD and the impact it had on their lives. 
The women did discuss the impact that having support had on their lives. The 
support for all came mostly from family and significant others. Not all of the women 
experienced positive support and one woman even described the loss of a relationship 
that she feels occurred as a result offfiD: 
I was only young and he was young and we just, it was just too 
hard to handle. I can see that happen especially when you 're 
young right. No I didn 'tfind that he was supportive when !first 
got it. 
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Most of the women felt that their partner was the most supportive person in their 
lives at this time. For one woman it was her husband to whom she vented all her 
negativity regarding her disease. She described maintaining a positive outlook on the 
exterior, but being able to truly be angry when she was with him: 
All my aggression on him, every bit of stress I felt went on him. 
He was wonderful. I was always mean to him the whole time. I 
think it was like a coping mechanism. You kind of play on that 
positive part of my personality and you put a positive outlook 
there so nobody really knows how upset I really was, and then it 
all kind of went to him and he took it. He bore the burden which 
wow when you think about that 's pretty amazing. 
While not all of the women described venting their anger with their partners, 
another woman confirmed that it was her boyfriend who was the basis of her supportive 
relationship: 
My family and my boyfriend and stuff, I mean I've been with him 
for two years and he 's done everything, like he's you know, been 
there for everything pretty much, and he always asks me, you 
know, "how's your bum. " 
Even though the women were able to develop a supportive relationship with 
their partners, the same was not always true for friends : 
I didn 't really t.alk about it a lot to my friends, right? Actually, I 
even found I lost a few friends because I couldn 't go out anymore 
and stuff 
Another big impact on me was my friends, you know the old 
saying; you know who your friends are when bad things happen. 
right? I mean I had no contact, basically, with the majority of my 
friends that I had before I was sick. Nobody wanted to talk to me 
because my whole life centered around being sick and trying to 
be healthy. I used to talk about it a lot. It was a major thing that I 
talked about. I think that kind of scared people off 
Accepting the Challenge of Living with IBD 
Living with IBD had presented a number of interrelated challenges for these 
women, but accepting the challenge and facing the future while living with IBD, 
allowed the women to move on and see other sides of the disease. The women 
described a personal growth and a learning that had occurred as a result of living with 
these challenges. 
Youleam as you go along, your still learning, there are still 
things you know, that surprise me. 
At the same time, after going through such a traumatic 
experience and adjusting to it, I 've grown from that. I think that 
other than having to live with Crohn 'sfor the rest of my life, it 
was a positive experience in the end because I've learned from it. 
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Over time, like J said, J find it's more common now and stuff and people 
are more aware of it then back then so I'm .finding it easier now, right? 
They described the many positives that living with IBD had on not just 
their lives, but also those of their families, and even on work life. In addition it 
gave them a better understanding of others and what they might be experiencing 
in their lives. One of the outcomes they noticed was that it had increased their 
sensitivities towards others. 
There 's so many things that impact young adults no matter what 
the health concern is. but in my particular situation my life 
changed completely. It was positive in my education wise, my 
parent's relationship and my husband's relationship with me 
blossomed. 
So I .find it really helps me with my work and it helps me 
understand other people. There are a lot of positives. I'm still 
figuring it out everyday. 
As well , the woman felt that the longer they lived with the disease the more 
empowered they have become. They had learned to handle their disease better and 
develop a degree of comfort that previously they did not have. As a consequence it is 
now easier to handle the challenges, to share with others, and to live successfully with 
IBD: 
But, you know it 's good like that, but I don 't really care if they 
:~re uncomfortable with it because I mean you know, I 'm open 
now, so more mature about it. So it doesn 't bother me, if it 
bothers them it's their problem. 
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Yes, and things like; there 's always something they can do if it 's not 
drugs then they can remove it all I 've heard and I 've heard a lot of 
stories about that but then I heard that sometimes when you get that 
done, the complete removal that you can still live a norma/life with that 
done. 
The longer they lived with the disease the more comfortable they were 
with various aspects of the disease. There was an adaption or an acceptance over 
time. They learned to live with it. Their disease was a part of their life and a part 
of them. 
Probably like the longer you have it the more you just start to 
realize different things that you shouldn 't eat and vou oecom: 
more experienced with it, you know what I mean? It's not so new 
to you; you 're not so scared as you are first when you 're 
diagnosed. 
Yes, but I think that definitely the longer you 've had it the better 
it will get like you know. It's definitely a lot better than when I 
was first diagnosed. You just get used to it and, you know, you 
learn how to deal with it better. 
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For these women living with lliD presented its share of struggles in their lives, 
yet they were also able to find significance in their ffiD experience and live successful 
and fulfilling lives. 
Summary 
Three women described what it was like to live with 1BD. The themes and a 
description of the themes that emerged from these personal accounts have been 
presented in this chapter. These themes were supported by direct quotes from the 
women that illustrated how ffiD had affected them and was continuing to affect their 
lives. In keeping with phenomenology as described by Colaizzi (1978) and valuing 
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individual experiences, this chapter helps to portray what it is like to live with mn and 
the impact it has on the lives of the women who participated in the research . 
Chapter 5 
Discussion 
Being a young adult, and in particular a young woman, living with 
Inflammatory Bowel Disease (IBD) is a complex experience. IBD such as ulcerative 
colitis (UC) and Crohn 's disease (CD) does have a profound effect on the lives of 
young adults who are affected. This research describes the many ways that the lives of 
individuals with ffiD may be affected. This chapter is divided into two main sections; 
the first section compares this research with other research on IBD and highlights some 
of the similarities and differences. In the second section I situate my research within 
the context of research and theoretical work that has been done on chronic illness. 
Living with IBD 
The findings from my study support a number of the findin gs from other studies 
that have been conducted with those who are affected by IBD, either CD or UC. While 
there are a number of similarities there are also differences. The women in my study 
repeatedly expressed concern, worry, and feelings of embarrassment about elimination 
and incontinence. This is a common concern that has been identified in previous 
research on IBD (Daniel 2001 ; Dudley-Brown, 1996; Hallet al. , 2005 ; Kinash et al. 
l993a). There was also a general struggle when dealing with disease symptoms that 
was evident in the women's stories. It was apparent that the physical symptoms of IBD 
and its treatments were constant, and had a major impact on daily life. In research by 
Dudley-Brown (1996), participants described their disease as affecting all aspects of 
their lives. They also expressed that UC controlled them. Given that symptom 
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experience plays such a prominent role in these women's lives it is not surprising that 
like Dudley-Brown's participants they often seemed to feel controlled by their disease. 
The uncertainty surrounding the nature of disease exacerbation and remission 
was another reoccurring theme in the women's experience. Living with ffiD creates a 
sense of vulnerability and a sense of lack of control over the disease process (Nicholas 
et al ., 2007). For the young adults in this study the uncertainty and unpredictability 
associated with living with ffiD was emotionally trying. Even though they were aware 
and understood the chronic nature offfiD, the women experienced a great frustration 
when their symptoms returned or worsened. The worry over the return of symptoms or 
the actual return of symptoms essentially had a negative impact on their quality of life. 
These findings are supported by previous research that demonstrated that increased 
numbers of exacerbations and an uncertain disease course are associated with a 
decreased sense oflife satisfaction (Bemklev et al. , 2005; Casellas et al., 2001 ; Daniel , 
2001 ; Dudley-Brown, 1996). 
For young adults ffiD interferes with their sense of normalcy and their ability to 
lead a normal life. In previous research involving participants living with ffiD, having a 
normal life was important, and often ffiD interfered with this ability {Brydolf & 
Segesten, 1996; Daniel, 2001; Dudley-Brown, 1996; Hallet al ., 2005; Nicholas et al ., 
2007). The young adults in this study often felt they missed out on experiences that 
other young adults were having. They felt that losing out on these experiences was 
directly related to being a young adult living with ffiD. Participants in the study by 
Brydolf and Segesten described a "sense of alienation" from themselves and their peers 
that resulted from having ffiD. Young adults are typically involved in many social 
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activities, but for these women, young adulthood was marred with missed activities and 
restrictions on social connections. They felt they lost friends as a result of having IBD. 
The young adults in Daniel's study expressed a similar concern over the effect their 
disease had on their relationships with others. 
Also impacting the young adult's sense of normalcy was their need to be near a 
washroom and/or always know where a washroom was located. While findings in 
previous research identified elimination worries as a major concern for those living 
with IBD, specific concerns around the location of a washroom were not as prominent 
as they were for these young adults. Findings by Hall et al. (2005) indicated that 
participants with IBD often planned trips around how available a washroom would be, 
and this was similar to the women in this study. 
Embarrassment about bowel symptoms and especially if fecal incontinence 
occurred, was another prominent factor that interfered with the women' s sense of 
normalcy. Thus a sense of stigma associated with anything related to the bowels was 
part of their experience. Socialization in many cultures makes the area of"bowel 
control" a taboo topic (Norton, 2004). Wilson (2007) studied the experience of fecal 
incontinence with 22 participants who for a variety of reasons had this symptom. She 
found that her participants were generally reluctant or unwilling to discuss this problem 
with others and that reluctance extended to health professionals. Johanson and Laffery 
(1996) identified fecal incontinence as the " silent affliction" because of the taboo nature 
of talking about bowel functioning. Likewise, Collings and Norton (2004) in their 
study with women who had fecal incontinence noted how socially isolating this 
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symptom can be, and how the negative repercussions it had on women's self-image had 
caused feelings of shame and embarrassment for some of the women. 
One aspect ofliving with ffiD for the married women in my study that was felt 
to have an impact on their ability to lead a normal life, was the limitations their disease 
and treatments placed on their ability to get pregnant. For these women this was a great 
loss that they had to cope with . It appears that this has not been explored in previous 
research on living with ffiD, but is a major impact that living with ffiD potentially has 
on a young adult's life. 
Dealing with the treatments of ffiD was identified as an important part of living 
with ffiD for these young adults. Side effects of treatment have been associated with a 
decreased quality of life (Bemklev et al ., 2005 ; Casellas et al., 2001 ; Hallet al., 2007). 
The women were very conscious of the many physical side effects of the medications 
used to treat their disease, in particular those caused by steroids and 
immunosuppressive medications. While there was much despair related to these side 
effects and the impact on their lives, there was also a realization that these medications 
kept their disease symptoms in check. These young adults, like Dudley-Brown's (1996) 
participants expressed the importance of finding a successful treatment. There were also 
many commonalities in the research findings ofHall et al. (2007) in that the young 
adults accepted the need for medication, but experienced a constant concern about side 
effects and the impact of being on medications long term. 
Previous research on ffiD has identified the importance of social support in 
successfully living with ffiD (Brydolf & Segesten, 1996; Daniel, 2001 ; Fletcher & 
Schneider, 2006; Jamieson et al., 2007). For the young women in my study having a 
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significant other to provide support was important. Although support was identified as 
also coming from their families, it was their partners who provided the basis for their 
supportive relationships. The women also described a sense of feeling more 
comfortable sharing about their disease to those who shared a similar experience. While 
participants in Hall et al. ' s (2005) study described the taboo nature associated with ffiD 
as a barrier to normality, little research exists regarding disclosing about ffiD to others. 
These young adults felt that it was often difficult and at times even unacceptable to talk 
about ffiD. For the most part they simply didn't talk about their disease to others. 
Living with ffiD as a young adult is not without its challenges. Living 
successfully and transcending the disease was a process that these women experienced. 
Each woman went through a process of learning to live with her disease and there was a 
sense of personal growth and acceptance. Finfgeld (2000) who studied courage in 
managing chronic illness found that in becoming courageous one learns how to work 
through dealing with the disease and its concerns, and moving beyond them. Many 
positives were described by the women when considering their life with ffiD. Living 
with ffiD had somewhat of a positive impact on things like their families, their 
education, their careers, their personal relationships, and their disease acceptance. 
The experience ofliving with ffiD for the young adults in my study is complex 
and multidimensional. Previous research on ffiD supports many ofthe findings of this 
study. There are some themes that were described in this study that have not been 
explored in past research that contribute to understanding what it is like to be a young 
adult living with ffiD. 
73 
Living With a Chronic Illness 
The findings of this study add to and expand previous research on living with a 
chronic illness. For those living with ffiD, day-to-day coping and functioning are 
affected, and a number of restrictions are placed on their ability to experience life in a 
way that is meaningful to them and as a consequence affects their psychological 
wellbeing. While many people with chronic illnesses must deal with the challenges that 
affect their psychological health (Thome & Paterson, 2000), it is important to know 
how different chronic illnesses with particular signs and symptoms affect individuals 
with the disease. 
lBD and the associated symptoms created feelings of embarrassment, 
uncertainty, a decreased sense of control, and threatened normalcy. These feelings were 
congruent with Price's (1996) suggestion that with any chronic illness, uncertainty 
about how to manage the body or treatment, a frustration with bodily functions, and an 
apprehension with how to maintain a "normal" social image. Managing the body, 
especially managing bowel function, was both a source of embarrassment and a 
restriction in what my participants felt they could do. 
Michael (1996) specifically examined how individuals with chronic illness 
integrated this illness in their lives. Although her participants differed from those in my 
study in terms of age range (greater range), gender (males and females), and diseases 
(diabetes, cardiovascular and respiratory disease, and arthritis), some ofher larger 
themes, but more particularly her sub-themes, were similar to my findings. As with her 
participants, the women in my study confronted loss especially the loss of 
connectedness. My participants felt somewhat isolated from others because of their 
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symptoms and need to be near a toilet during exacerbations. Another similarity with at 
least some of her participants was that the women in my study could view their illness 
in a positive manner. 
Living with IDD involved a definite amount of uncertainty for the young adults 
in my study. Lundman and Jansson (2007) who studied meaning when living with long 
term disease also found participants, none of whom had IDD, experienced a great deal 
of uncertainty. This uncertainty was mainly a result of the disease impact in everyday 
life rather than the disease itself. While narratives from my participants demonstrate 
that there is uncertainty with the disease itself, similar to Lund man and Jansson 's 
participants, there was uncertainty because of the impact of the disease on daily life. 
This was evidenced from worries about elimination and incontinence, social 
acceptance, and missing out on activities. For both my participants and Lundman and 
Jansson 's it was quite a challenge to live life while surrounded by this uncertainty. 
The participants in my study described both the emotional impact of dealing 
with the unpredictable nature ofiDD. This finding is commonplace in research on 
living with other chronic diseases. Cunningham and Jillings (2006) in their research of 
individuals living with fibromyalgia revealed how their participants described the 
emotional and psychological impact living with the disease had on their lives. The very 
nature of the variability and unpredictability of the symptoms offibromyalgia was a 
contributor to this. Like these participants with fibromyalgia, the young adults living 
with IDD in my study felt the unpredictability of disease symptoms affected their 
emotional and psychosocial functioning. They described instances when the symptoms 
ofiDD were so unpredictable they were afraid to make plans, travel, or socialize. Not 
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knowing which symptoms they would have when or when the disease might flare again 
at times played havoc on their emotions and sense of well-being. 
Unlike the participants with fibromyalgia in Cunningham and Jillings (2006) 
study that talked about the challenges because of the difficulties surrounding getting a 
diagnosis, IBD has specific diagnostic criteria. So this was not a particular challenge 
that my participants faced . Regardless of any difficulty surrounding getting a diagnosis, 
participants in both studies expressed a desire for a cure or improvements in medical 
treatments. The benefit/risk nature of medications used to treat their disease was a real 
concern for both groups and finding a livable balance between side effects of 
medication and symptom control was an important aspect of living with chronic illness. 
Finally whi le both groups lived almost daily with the challenges presented by their 
diseases, they described the importance of trying to stay positive. 
Conrad, Garrett, Cooksley, Dunne and Macdonald (2006) studied individuals 
living with hepatitis C. Like lBD the symptoms of hepatitis C were often unpredictable 
and caused much disruption in the life of a person living with either ofthese chronic 
diseases. Participants living with hepatitis C described occasions when they felt like 
they had to remove themselves from the world until they got better. The young adults 
with lBD in my study described occasions where they just didn ' t feel well enough to 
carry out their normal lives and activities. 
Lempp, Scott and Kingsley (2006) completed research on the impact of 
rheumatoid arthritis on patient's identities. The key themes that arose from their 
participants were similar to some of those that were identified for the young adults 
living with lBD who participated in my study. Themes surrounding the emotional 
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impact of the disease, worries about the future, concerns about pregnancy, positive and 
negative work experiences, changes in physical appearance, changes in social activities 
and changes in self image were all themes identified by those living with rheumatoid 
arthritis that showed similarities for the participants of my study. 
Young adults living with IBD share many of the same experiences as those 
living with other chronic diseases. Comparison to several different chronic diseases was 
made in the preceding discussion, and demonstrates that living with chronic illness 
shares many of the same experiences. While the experiences of the young adults in my 
study share many similarities to those living with other chronic illnesses, the lived 
experience of being a young adult with IDD identifY some of the specific challenges 
faced. 
The Shifting Perspectives Model of Chronic Illness 
In considering theoretical work that has been completed on living with chronic 
illness I choose to look at Paterson 's (2001) shifting perspectives model of chronic 
illness. According to Paterson 's model the chronic illness experience "contains 
elements of illness and wellness" (p. 23). Both the perspectives of illness and wellness 
are present but depending on the situation one will take precedence. When illness is in 
the foreground the focus is on aspects of illness such as sickness, suffering, loss, and 
burden. When illness is in the foreground the person living with chronic illness is 
engrossed in illness experience. This perspective commonly occurs with diagnosis or 
onset of new symptoms which forces a person to concentrate on their illness, which in 
tum aids in refection and acceptance of the disease. 
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The second perspective in the shifting perspectives model is that ofwellness in 
the foreground (Paterson, 2001 ). When this perspective is in the foreground the focus is 
on an evaluation of the illness as an "opportunity for meaningful change in relationships 
with the environment and others" (p. 23). The focus is on the self and not the disease as 
shaping the person ' s identity. There is a separation from the body and the mind. 
Wellness can become the foreground when people living with chronic disease learn as 
much as they can about their disease, develop supportive environments, and acquire 
skills such as negotiating, understanding the body' s responses, and sharing knowledge 
about their disease. There is often a positive move to a focus on the spiritual, 
emotional, and social areas oflife, without the body being the main focus . 
A "threat to control" is a major factor in a shift from wellness in the foreground 
to illness in the foreground (Paterson, 2001 , p. 24). If this threat goes beyond the 
person ' s coping a shift from wellness to illness in the foreground can occur. Once a 
person realizes that they have shifted perspectives, they can identify the need for 
change and produce change or accommodation to the situation that has caused an illness 
focus. This may be a sudden or gradual process. 
According to Paterson {2001) there are several paradoxes evident in this model. 
First, is that a person living with a chronic disease, even though wellness may be in the 
foreground, needs to pay attention to the disease in order for wellness to remain in the 
foreground. The person must also acknowledge and deal with change and loss as part of 
the perspective ofwellness in the foreground. Second, those living with wellness in the 
foreground often have to shift to an illness in the foreground perspective when 
receiving health care or receiving help from others. 
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Neither perspective in the model is right or wrong (Paterson, 2001 ). While a 
person may more commonly have wellness in the foreground the perspective is not 
fixed and a person will change between the two perspectives in order to meet their 
needs or situations. This model allows for a constantly shifting change between the two 
perspectives as a normal occurrence. 
In the narratives provided by the young adults in my study one can see by means 
of sharing their experience they were focusing on an illness in the foreground 
perspective, and as they shared difficult situations in living with their disease they were 
focused on their body as diseased. There were times sharing their experiences when 
they seemed to realize this focus and were quick to point out situations or experiences 
where one could see that wellness was in the foreground. When sharing their stories as 
an overall experience there seemed to be a wellness in the foreground perspective 
present and a sense of disease acceptance and hope for the future. 
Summary 
Living with ffiD for the young adults in this study shared many similarities to 
other research completed on living with ffiD. The experience of these young adults 
adds to and validates previous research on ffiD. It is important to note that there were 
some differences identified in my study that do not appear to be present in previous 
research. The experience ofliving with ffiD while diverse, shares many of the same 
themes that those living with other chronic illnesses experience. Finally living with ffiD 
is situated in the shifting perspectives model of chronic illness. 
Chapter 6 
Limitations and Implications 
Limitations 
There are potentially some limitations to the current study. The limited number 
of participants affected my ability to describe as fully as I would like the experiences of 
young adults with inflammatory bowel disease (IBD). I experienced a great deal of 
difficulty in finding eligible participants. Participants were recruited with the help of 
physicians and nurses and this was in keeping with the approval of the ethical review 
board that reviewed the research . I do not know to what extent these individuals were 
active in participant recruitment, or how many individuals they approached, or how 
many did not want to be part of the study. Participant volunteers were few in number 
and spaced over a long time frame . 
My initial contact with physicians to aid in recruiting participants was 
unsuccessful. When I made follow-up with the physicians via their secretaries to check 
on recruitment, I often found that my participant letters were often misplaced or sitting 
in their original envelopes with none given to potential participants. One physician, 
when contacted a second time, reconsidered my request for assistance, and requested I 
contact his secretary to arrange an appointment with him to discuss the research in 
further detail. When I met with him I was told that he was no longer able to assist me as 
he had ongoing research and was recruiting participants. In an area with a small 
population base and a number of researchers actively recruiting participants, the 
competing demands for research participants are great. The three volunteers who 
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participated in the research were recruited with the help of nurses in the endoscopy 
units. 
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A further potential limitation of the study was that because data collection 
occurred solely through interviews, my developing ability to conduct the interviews 
may have influenced the quality of the participants' descriptions. While I tried to 
maintain a good dialogue in my approach to interviewing, at times I needed to rely on 
questions. Using interview questions to elicit a description of the participant's 
experiences, in contrast to their theoretical knowledge of the topic, depends on the skill 
of the researcher (Colaizzi, 1978). One of my interviews was conducted via telephone 
and although this participant requested this method because of the nature of her job and 
the amount of travel involved, it did restrict my ability to see how she presented herself 
during the interview and may have affected how I interacted with her. 
A third limitation is although I had provision for a second interview with each 
of the participants, when I telephoned them to get validation of the themes, that I had 
identified none of the participants had any new information to add, thus the findings are 
based primarily on one interview. The women did confirm what I presented to them 
and reiterated some of what was contained in the first interviews. Data collection was 
not through prolonged engagement with participants as is sometimes the case in 
phenomenology. 
Implications for Nursing Practice 
There are implications for nursing practice that are apparent in the findings from 
this study and that support what has been found in other studies ofindjviduals with 
lBD, although these implications need to be considered with caution and in light of the 
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limitations I have identified. First, understanding and being familiar with the chronic 
illness experience, as well as the effects that a particular disease can have on daily 
living, is very important for nurses to consider when interacting with individuals 
affected. Nurses have the opportunity to encourage people with IBD to actively 
participate in decisions regarding their health. The women in my study illustrated the 
importance for individuals with IBD to be able to take control of their health and 
actively search for ways to manage their disease. A partnership role with the nurse can 
provide clients with access to such things as support through therapeutic 
communication, teaching, referrals, resources, and alternatives or adjuncts to 
medication and surgery. Mishel (1 999) indicated that although there are few studies that 
examine the role of health care professionals in the chronic illness experience, it has 
been identified that health care professionals are important. In particular, health care 
professionals have a vital role in such things as assessment and establishing a diagnosis, 
assisting with self-management of the disease or illness, and promoting wellness and a 
sense of normalcy for clients. 
During the transitions and challenges throughout the course of the disease, 
nurses can provide much needed support for the client. Letting the client know that it is 
normal to experience fear, uncertainty, and frustration can be very important. Active 
listening on the part of the nurse can communicate a nurse's interest and understanding 
to the client. Active listening in order to gain an understanding of the illness experience 
is no doubt challenging and time consuming. Yet, at the same time, active listening 
provides the nurse the opportunity to consider more than the physical problems and to 
help identify the influence and effects that the disease has on a client's life, as well as 
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the coping strategies utilized by the client. Gaining a better sense of what the client is 
dealing with will enable the nurse to develop a more inclusive plan of care and support 
for the client. This more inclusive framework will help foster client empowerment and 
encourage the client to participate in the management of his or her individual health and 
wellness process. 
Nurses need to recognize the importance of recognizing the "individuality" of a 
client's experiences in living with IDD. The effects that IDD can have on a person 's 
life, while at times encompass many commonalties, may also vary based on the 
person ' s social support network, self-awareness, confidence, and self-management 
strategies. According to Sharoff (1997), in her research on people' s experiences of 
disease within chronic illness, interventions and support must reflect the client's present 
state and incorporate the individual 's perception of their needs. Thus, a thorough 
assessment of functioning, sense of well-being, and goals is necessary. 
Promotion of independence and self-care during the illness experience may 
heighten autonomy and promote support seeking (Delmar et al ., 2006). As well, 
continuous interactions and reassessment of the client can help the nurse identify the 
client's needs more accurately. Accurate assessment can help the nurse develop an 
individualized plan of care incorporating the client needs, strengths, and challenges. 
The nurse also has the opportunity to increase her/his awareness ofiDD from 
the client's perspective in order to help establish helpful resources and supports that 
will reinforce or provide new options for clients living with IDD. The findings 
demonstrate that there is a need for a multidisciplinary role in caring for the client with 
IDD, which would include ensuring continuity of care, promoting a positive self image, 
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and identifYing and minimizing treatment side effects when possible. Helping the client 
access additional resources and information on such things as diet, alternative 
treatments, and coping strategies would be useful . As the nurse assumes a partnership 
role with the client who is living with ffiD, she/he may help in creating a much more 
meaningful and fulfilling experience, thus promoting health and wellness within 
disease. 
Education of the public regarding ffiD and how it affects a person's life may 
enhance public understanding and alleviate feelings of embarrassment on the part of the 
person with ffiD. Education and increasing awareness of the public may also provide 
persons with ffiD a more supportive and accepting environment in which to live. 
Increasing support on the part of the public, and the nurse, may help alleviate some of 
the frustration experienced by people with ffiD when attempting to overcome some of 
the many challenges that can be experienced, such as body image alterations, managing 
symptoms, and maintaining normalcy. 
Some of the nursing literature on fecal incontinence and the stigma associated 
with this symptom could be helpful to the nurse in addressing that particular problem 
(Garcia, Crocker, & Wyman, 2005; Mason, 2007). There are some ways of addressing 
the problem of fecal incontinence and helping patients explore their feelings about the 
symptom. On a broader level, public education can help to make the problem of fecal 
incontinence, not such a stigmatizing condition. 
An understanding of the influence offfiD on a person 's life, and also the effects 
of treatments, can enhance the nurse' s ability to provide support and care for the client 
with ffiD. Promotion of a positive self-image and self-concept for the person dealing 
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with body image disturbances can subsequently encourage more social interaction and 
sharing. Increased social interaction can enable the client with IBD to deal with the 
changes in body image and can help increase her/his sense of acceptance by others, and 
overall sense of normalcy. 
My findings indicate that persons with IBD experience feelings of uncertainty 
when living with IBD and this finding has been noted in other studies. Facilitating and 
promoting health within illness can enable acceptance ofiBD as well as increase a 
person's desire to achieve a quality of life that is acceptable to them. Promotion of 
optimism as well as actively listening to fears and uncertainties can aid individuals in 
transcending IBD. 
Implications for Nursing Education 
Along with nursing education on the etiology, treatments, and side effects of 
treatments for IBD, promotion of a framework in nursing education that examines 
broader factors can enhance the nurse's ability to care for the client with IBD. 
Consideration of the mind-body-spirit connection for the individual living with IBD can 
provide nurses with an enhanced ability to care for the whole person. Incorporation of a 
wellness model in nursing education allows nurses to support a person with IBD who 
may be struggling to achieve a sense of wellness while living with the disease. 
Integration of the present research findings, along with other qualitative research on the 
experiences of living with IBD, can provide student nurses with the knowledge 
necessary to care for the whole person . 
One area the nurse-educator can address is teaching students about the area of 
stigma and fecal incontinence. By having this as a discussion topic with students, the 
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nurse educator can help students learn to deal with some of the more difficult areas of 
nurse-patient interaction, as well as teaching students about how to employ "problem-
solving" around how to deal with the symptom (Mason, 2007). lf nurses learn to be 
more comfortable with certain topics they may be more likely to explore them with 
their patients. 
As well, nursing education that promotes critical thinking can produce nurses 
who are able to consider more then the physical effects offfiD. Critical thinking can 
challenge student nurses to become active listeners and interpreters ofthe needs of 
clients with IBD. Perhaps, nurses who have acquired the skill of critical thinking can, 
in the future, develop enhanced nursing interventions in the care ofthe client with IBD. 
Implications for Nursing Research 
As a result of the findings from this study, there are several implications for 
nursing research. Further research is needed on the experiences of young adults living 
with IBD in order to determine what it is like to live with IBD during the young adult 
years and to expand on how being a young adult can have an impact on life with IBD. 
My research is a beginning effort in this work. 
Other areas of research on living with IBD could also be explored, such as the 
experience of males, or persons of varying cultures living with the disease. Further 
research could examine partners/spouse and family members experiences as well . This 
type of research could determine if different types of supports and care are necessary 
for these particular groups and individuals as they live with or support someone with 
IBD. 
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One of the themes, Accepting the Challenge of Living with JED, suggests a 
psychosocial process has occurred in which some resolution with this condition has 
occurred. It is not known if this is a usual outcome, or something particular to the 
women who volunteered to take part in my study. Further research could occur, using 
grounded theory, to examine that process. This would allow for identification of what 
conditions enhance or act as barriers to acceptance, what are the stages of acceptance, 
and what variations occur in the process. 
Finally, a longitudinal study could look at different times in the illness 
experience ofliving with ffiD to determine if disease experience and perceptions 
change over time. This may provide nursing with better knowledge and tools needed to 
identify the supports and care needed at various stages of the disease and life, thereby, 
enhancing the persons abilities to live with the exacerbation-remission cycles of the 
disease. 
Conclusion 
A phenomenological approach was chosen to investigate the experiences of 
young adult' s li ved experience with inflammatory bowel disease. Three participants 
living with inflammatory bowel disease and meeting the sample criteria were recruited 
to provide rich descriptions of the experience. Each participant's lived experience with 
inflammatory bowel disease was shared through an interview. Colaizzi ' s (1978) method 
of data analysis was used to identify pertinent statements of experiences with ffiD, 
cluster these statements into themes, and to write a rich description of the themes. 
Findings were presented through these themes and supported by direct quotes from the 
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participants. A number of implications for nursing practice, education, and research, 
were evident from the findings. The experience of living with inflammatory bowel 
disease touches all aspects of a person 's life. Inflammatory bowel disease impacts the 
whole person -impacting not only the physical, but also the social, emotional, and 
spiritual aspects of a person's life. Nurses have many opportunities to share in the lives 
of those living with inflammatory bowel disease and through a more inclusive broad 
approach, can help clients to live with and transcend their many challenges. 
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Appendix A: Letter to Local Gastroenterologists/Nurses 
63 Chanterelle Drive 
Con. Bay South, NL 
AIW 4E4 
709-834-2149 
n lJI (1t ,lc\ u nl rogers com 
September 11 , 2004 
Dear [Dr. /Ms.] 
My name is Tracy-Lee Faulkner and I am a graduate nursing student at Memorial 
University of Newfoundland. I am conducting research on the experiences of young 
adults living with inflammatory bowel disease. I feel that results of this study could 
enhance nursing understanding of what it is like to be a young adult living with 
inflammatory bowel disease. 
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I am looking for potential participants for this study. Participants for this research 
should be between the ages of 19-29; be able to speak, read and write English; are 
followed by a local Gastroenterog1sts conducting clinics in locations run by Eastern 
Health, Newfoundland, Canada; have been diagnosed and living with inflammatory 
bowel disease (either Crohn's disease or ulcerative colitis) for a minimum of one year; 
and do not have an ostomy. 
I am requesting your help in accruing participants for this study. If you have patients 
who fit the criteria could you please provide them with the potential participant letter 
and if they are agreeable, have them consent to providing me with their name and 
contact information . 
If you are interested in finding out more information about this research or have any 
further questions please do not hesitate to contact me at 834-2149. Once your patients 
have consented to having me contact them, I will pick up the forms. I will contact your 
office on (date) to see if any completed forms are ready. This research will be 
confidential and is approved by Memorial University ' s Human Investigation 
Committee. 
Thank you for considering this request and I will be in touch. 
Sincerely, 
Tracy-Lee Faulkner, B .Sc.N, R.N 
100 
Appendix B: Form Provided to Physicians/Nurses to Recruit Participants 
\ 
63 Chanterelle Drive 
Con. Bay South, NL 
AIW 4E4 
709-834-2149 
l,tlllll ,\L\ 1111 .oger com 
June 5, 2004 
Dear Young Adult Living with Inflammatory Bowel Disease; 
My name is Tracy-Lee Faulkner and I am a graduate nursing student at Memorial 
University ofNewfoundland. I am conducting research on the experiences of young 
adults living with inflammatory bowel disease. I feel that results of this study could 
enhance nursing understandingofwhat it is like to be a young adult living with 
inflammatory bowel disease. 
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I am looking for potential participants for this study. Participants for this research 
should be between the ages of 19-29; be able to speak, read and write English ; are 
followed by a local Gastroenterogists conducting clinics in locations run by Eastern 
Health, Newfoundland, Canada; have been diagnosed and living with inflammatory 
bowel disease (either Crohn ' s disease or ulcerative colitis) for a minimum of one year; 
and do not have an ostomy. If you are unsure if you meet these criteria, your Doctor can 
help you determine your potential eligibility. 
If you are interested in finding out more information about this research and your 
potential participation I would like to contact you. If you are willing, I am requesting 
that you provide your name and contact information on the next page. Once you have 
provided this information, I will pick this form up from your doctor and call you. 
This research will be confidential. It will not affect your current health care. Although 
your Doctor will know you provided your contact information to me, he/she will not 
know whether you have decided to participate or not. 
Thank you for considering this request and I hope that you will allow me to contact you 
and provide more information about the research. 
Sincerely, 
Tracy-Lee Faulkner, B.Sc.N, R.N 
As a potential participant, please retain this letter for your records 
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Young Adult's Living with Inflammatory Bowel Disease 
! ___________________ would like to learn more 
information 
about the research study looking at the experiences of young adult living with 
inflammatory bowel disease. I give permission for the researcher to contact me at the 
phone number provided below. After learning more about the research, I am under no 
obligation to participate in the research. 
Date: 
-------------
Name: 
-------------
Cicy/Town: ____________________ _ 
Phone Number: ____________ _ 
Completed form to be returned to researcher by physician 
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Appendix C: Consent Form 
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October 2003 
Faculty of Medicine, Schools ofNursing and Pharmacy ofMem01·ial 
Univet·sity of Newfoundland; Health Care Corporation, St. John's; Newfoundland 
Cancer Treatment and Research Foundation 
Consent to Take Part in Health Research 
TITLE: Young Adults Living with Inflammatory Bowel Disease: A 
Phenomenological Study 
INVESTIGATOR(S): Tracy- Lee Faulkner 
You have been asked to take part in a research study. It is up to you to decide whether to be in 
the study or not. Before you decide, you need to understand what the study is for, what risks 
you might take and what benefits you might receive. This consent form explains the study. 
The researchers will: 
• discuss the study with you 
• answer your questions 
• keep confidential any information which could identify you pe•·sonally 
• be available dut·ing the study to deal with p.-oblems and answe•· questions 
If you decide not to take part or to leave the study this will not affect your usual health care 
1. Introduction/Background: 
Young adults face many challenging tt·ansitions in their lives. These transitions 
may be even gt·eate•· when you also live with inflammatory bowel disease (IBD). 
Ther·e is not a great deal of r·esearch that infor·ms nur·ses and other· healthcar·e 
professionals about what it is like for a young adult to have ffiD, how it affects 
their lives, and some of the adaptations they have to make. This study will provide 
a greater understanding of young adults who live with ffiD. 
2. Pm·pose of study: 
I am conducting this study for two reasons. The first reason is to describe the 
experience of living with inflammatory bowel disease as a young adult. The second 
•·eason is to gain a greater understanding of the experience ofliving with 
inflammat01-y bowel disease as a young adult. I hope this will help nurses and 
othe•· health cat·e pt·ofessionals who wot·k with young adults that have 
Inflammatot-y Bowel Disease. 
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3. Desc•·iption ofthe study procedures and tests: 
Du.-ing the first interview, you will be asked to sha•·e your expe•·iences as a young 
adult living with inflammatory bowel disease. You will be asked questions to help 
you share your expelience. Duling the second interview with you I wiD share my 
inte•·p•·etations of your experience. I wiD ask you whether or not you feel these 
findings accurately reflect your expelience. You can share any other information 
about yom· expe•·ience at this time. With your permission, I will audio •·eco•·d both 
inten•iews. Upon completion of the study I will keep the audio-tapes ofyom· 
inten•iew. All inf01·mation you p•·ovide including your identity will be kept 
confidential. 
4. Length of time: 
You will be expected to participate in two interviews. Each inteniew will last 
app•·oximately one hour. The interviews will take place at a location that is 
comfo11:able and private to you and at your convenience. Following the interview a 
transcliption of the interview wiD be made. 
5. Possible risks and discomforts: 
You may expe•·ience emotional distress duling and following the interviews as a 
result of sharing your experience. I will call you the day after each interview, to see 
if you are expeliencing any distress, and if so provide you with the name and 
number of a support person. 
6. Benefits: 
This study will have no di•·ect benefit for you. You may benefit f•·om sharing yom· 
experience. 
7. Liability statement: 
Signing this form gives us your consent to be in this study. It tells us that you 
understand the information about the research study. When you sign this form, you do 
not give up your legal rights. Researchers or agencies involved in this research study 
still have their legal and professional responsibilities. 
8. Questions: 
If you have any questions about taking part in this study, you can meet with the 
investigator who is in charge of the study at this institution. That person is: 
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Tracy-Lee Faulkner (709) 834-2149 
01· you can talk to someone who is not involved with the study at all, but 
can advise you on your ri2hts as a participant in a research study. This person can 
be •·eached th•·ou2.h: 
Office of the Human Investigation Committee (HIC) at 709-777-6974 
Email: I n mnn.ca 
-2- tnilials: __ _ 
Signature Page 
Study title : Young Adults Living with Inflammato•-y Bowel Disease: A 
Phenomenological Study 
Name of principal investigator: Tracy-Lee Faulkner 
To be filled out and signed by the participant: Please check as appropriate: 
I have read the consent Yes { } No {} 
No {} 
No {} 
No {} 
I have had the opportunity to ask questions/to discuss 
this study. Yes { } 
I have received satisfactory answers to all of my questions. Yes { } 
I have received enough information about the study. Yes { } 
I understand that I am free to withdraw from the study 
• at any time 
• without having to give a reason 
• without affecting my future care health care 
I understand that it is my choice to be in the study 
and that I may not benefit 
I agree to take part in this study. 
I agree to have my interviews audio-recorded 
Signature of participant 
Signature of witness 
To be siened by the investieator: 
Date 
Date 
Yes { } No { } 
Yes { } No { } 
Yes { } No { } 
Yes { } No { } 
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I have explained this study to the best of my ability. I invited questions and gave 
answers. I believe that the participant fully understands what is involved in being in the 
study, any potential risks of the study and that he or she has freely chosen to be in the 
study. 
Signature of investigator Date 
Telephone number: 
-3- lnjtials: __ _ 
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Appendix D : Interview Questions 
Interview Guide 
Thank-you for agreeing to take part in my research about young adults who live with 
inflammatory bowel disease. Please tell me about being a young adult living with 
inflammatory bowel disease. 
The following questions may be used as a guide by the researcher in exploring the 
young adults ' lived experiences with inflammatory bowel disease. 
1) When did you first experience inflammatory bowel disease? 
2) When was the diagnosis ofiBD made? 
3) How did you feel about this diagnosis? 
4) What has your life been like since your diagnosis? 
5) Describe those things that make your condition worse or better? 
6) Who are the people who have provided you with help? 
7) Who do you tum to or draw on for support? 
8) Who do you think could provide you with help? 
9) What are the things you do that help you deal with this disease? 
1 0) Describe some specific times when IBD has affected your life? 
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Appendix E : Table 1 
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Table 1 
Significant Statements, Formulated Meanings, and Cluster of Themes 
Significant Statements 
I found out it [Imuran] 
actually inflamed my 
pancreas, so I had to 
stop taking that one. 
They [drugs] are not 
nice at all. 
He [physician] put me 
on steroids, first of all, 
Prednisone, obviously 
it's a pretty risky drug 
They have to wean you 
off it because it's such 
a risky drug 
Pretty much got me 
back to normal. I mean 
I had side effects- a 
swollen face- joint 
soreness 
I got to the point, I 
don't care [about side 
effects] whatever, it 
takes to get this pain 
taken away 
I don'tcare if I was on 
Prednisone right now 
and looked as big as a 
whale 
When you're on high 
doses of Prednisone 
your face looks like it 
gained 30 lbs. and 
nobody understands 
Formulated Meanings 
Because ofthe side 
effect she had to stop 
taking the drug even 
though it helped 
Concern about effects 
of drugs 
Concern about effects 
of drugs- understands 
aspects of risk 
Understands risk with 
drugs 
Drug worked but also 
had side effects 
Realizes that even 
though she has side 
effects, the drug works 
Willing to put up with 
risks of drug as long as 
it helps 
Others lack of 
understanding of 
Drug and side effects 
Cluster of Themes 
Double edge sword: 
Treatment can be as 
difficult as the disease 
----------------- -- ----~----~ 
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Appendix F: HIC Approval 
\lemorial 
Universit) of Ne\\ foundland 
I Iuman Investigation 
Commillec Research and 
Grnduale Studies I 'tcult' ,,r 
k·hun.: The llcallh 
Sciences Centre 
ovcmber 10, 
Reference 
#04.190 
t\1rs Trac •-Lee Faulkcr 
C o Dr. Simi y Solberg 
chool of 'ursmg 
1emonal Uni\ ersit of C\\ foundland 
2"J Floor. H S C 
Dear l\1rs. Faulkner: 
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Thts wtll acknowledge your correspondence dated October 21. 2004, \\herein vou 
clarifted Issues and provide a revised C( nscnt form for your research stud 
entitled "Young adults living with inflammatory bowel disease: \ 
phenomenolo~ical stud)·". 
\t the meeting held on Septem bcr· 30. 200-l, the imtial renew date ofthts study, 
the Human Im·cstigation Committee CHIC) agreed that the response and re\ised 
consent fom1 could be reYie"~ed by the Co-Chairs ami if found acceptable. full 
approval of the study be brranted. 
l he Co-Chairs of the HIC revie\\Cd y.our correspondence. appro\ eel the 
rc\·ised consent form and. under the directiOn of the Commtitc . granted full 
upprom/ of your research study. This" Ill be reported to the full Human 
lnYestigat1on Committee. for their informntton at the rneerin~ "Chcduled for 
~ovem ber· 18. 200-l. 
Full approval has been gnmted for one ~rear. You will be contacted for annu(!l 
update in September 2005. 
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1\lodifications of the protocol/consent are not permitted without prior approval 
from the Human Investigation Committee. Implementing changes in the 
protocol/consent without HlC appmval may result in the app•·oval of your 
research study being revoked, necessitating cessation of all related research 
activity. Request for modification to the protocol/consent must be outlined on 
:m amendment form (available on the HIC website) and submitted to the HIC 
for review. 
For a hospital-based study. 1t is vour responsibilitv to seek the necessary 
approval from the Health Care Corporation of St. ,John's and/or othc1· hospital 
boards as appropriate. 
Thts Research Ethics Board (the HIC) has re\ iev.ed and approwd the application 
and consent form for the study which is to be conducted b) you as the qualified 
mvest1gator named above at the specifted study site Th1s approval and the views 
of this Research Ethics Board have been documented in \\Titmg In add1tion. 
please be advised that the Human InvestigatiOn Committee currently operates 
according to the Tn-Council Polley Statement and applicable laws and 
regulations . The membership ofthis research eth1cs board complies with the 
membership requirements for research ethics boards defined in Division 5 oft he 
Food and DrU!! RegulatiOns. Nonv1thstandmg the approval of the HlC, the 
pnmary responstbi lity for the ethical conduct of the mvest1gation remams w1th 
you. 
\Ve wish you every success your study 
Smcerelv. 
John D. Harnett, MD, FRCPC 
Co-Chair 
Human Investigation Committee 
JDH;RSN\jd 
Richard S. Neuman, PhD 
Co-Chair 
Human Investigation Committee 
C Dr. C. Loomis, Vice-President (Research), MUN 
Mr. W. Miller, Director of Planning & Research, HCCSJ 



